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Chapter I 
INTRODUCTION AND PROBLEM STATEMENT 
In 1966 Michielsen and co-workers introduced the antiphlogis-
tic indomethacin in the treatment of glomerulonephritis. Their 
starting-point for using this drug was the observation that indo-
methacin can significantly reduce proteinuria in patients with a 
nephrotic syndrome. Similar effects on proteinuria in the nephro-
tic syndrome had been previously observed from the antiphlogistics 
aminophenazone and phenylbutazone (Fieschi et al. 19 55; De Vries 
et al. 1960; Fieschi et al. 1965), and were subsequently also 
observed from oxyphenbutazone (Wijdeveld 1971). Although the ob-
servation of Michielsen and co-workers was corroborated and ela-
borated in detail by themselves (Michielsen et al. 1967, 1969, 
1970, 1973, 1975) and by others (Conte et al. 1967, 1970, 1975; 
Wijdeveld 1971; Renner et al. 1971; Pierron et al. 1971; Lagrue 
et al. 1971, 1973; Clarkson et al. 1972), the effect has so far 
remained unexplained, although hypotheses on possible mechanisms 
of action have of course been advanced. 
The first possibility is that indomethacin limits the patholog-
ical process in the glomeruli as such. If this could be demon-
strated, then a therapy which delays the course of chronic 
glomerulonephritis would be available. Michielsen and co-workers 
have advocated this possibility, both on morphological facts 
(Michielsen et al. 1970) and on the basis of an analysis of pro-
tracted follow-ups on patients with chronic membranoproliferative 
glomerulonephritis (Michielsen et al. 1975). However, their mor-
phological findings have no so far been confimed by others 
(Conte et al. 1970; Wijdeveld 1971), nor have they been observed 
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in experimental nephritis (Gribnau 1975). In lupus nephritis, 
there may be a favourable effect of long-term indomethacin medi-
cation, alone or in combination with corticosteroids (Wijdeveld 
1971) or chloroquine derivatives (Conte et al. 1973, 1975); and 
the same may be the case in menbranoproliferative glomerulone-
phritis (Michielsen et al. 1975). For other clinical and experi-
mental forms of glomerulonephritis, this has not so far been 
demonstrated. Nevertheless, it is certain that patients with 
proliferative and extramenbranous glomerulonephritis with 
initially normal glomerular filtration can deteriorate to the 
terminal phase of renal failure in spite of (and during) years of 
indomethacin treatment (V7ijdeveld 1971). Whether the progression 
of the renal affection is delayed by indomethacin, and to which 
extent, cannot be concluded from such individual observations. 
An alternative possibility of explaining the effect of indo-
methacin is based on detailed studies of this effect on various 
parameters of renal function. One of the striking facts is that 
the effect on proteinuria is nearly always visible on the first 
day of indomethacin medication, and disappears within a day or at 
best a few days when the medication is discontinued. Moreover, 
the effect is often associated v/ith a decrease in endogenous cre-
atinine clearance (reversible after discontinuation), and some-
times also with a decreased excretion and clearance of other dis-
solved constituents (Wijdeveld 1971; Arisz et al. 1975, 1976). 
Indomethacin has also been reported to cause immediate, marked in-
activation of even strong diuretics (Tiggeler et al. 1977). These 
observations seem to suggest that the effect on proteinuria is 
better explained by an influence on physiological renal function 
than by a modification of a pathological process localized in the 
glomeruli. Otherwise, this suggestion is not supported by the ob-
servation that indomethacin has been administered, over the years, 
to large groups of patients with chiefly rheumatic pathology, with 
only incidental reports of an untoward effect on renal function. 
A survey of the relevant literature, supplemented with personal 
observations on the absence of an effect of indomethacin on endo-
genous creatinine clearance in healthy volunteers, can be found 
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in Gribnau's thesis (1975). These data could lead to the assump­
tion that an effect of indomethacin on physiological renal func­
tion, if any, becomes manifest only or particularly in glomerulo­
nephritis or a nephrotic syndrome. In this context it is of im­
portance that indomethacin is an inhibitor of prostaglandin syn­
thesis (Vane 1971; Ferreira and Vane 1974); renal prostaglandins 
seem to play an important role in the regulation of renal blood 
flow (Itskowitz, McGiff et al. 1973, 1974; Zins 1975), with an 
effect related and contrary to the activity of the renin-angio­
tensin system (Werning et al. 1971; McGiff et al. 1973; Lee 1974). 
The renal prostaglandins E2, F2
a
 and Λ2 are synthesized in the 
osmiophilic cells of the renal medulla (Lee et al. 1967; Muir-
head et al. 1972), and E2 and F2
a
 are the moet important, the 
suspicion being that Λ2 results from enzynatic dehydration of E2 
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(Zins 1975). In rats, the incorporation of C-labelled arachi-
donic acid in the microsomal lipids of the medulla proves to 
decrease significantly during indomethacin medication, whereas 
at the same time the amount of granules in the interstitial cells 
of the medulla decreases (Limas et al. 1976). 
A third possibility to explain the effect of indomethacin 
could lie in an influence on the permeability characteristics of 
the glomerular basement membrane, either via a change in the 
structure of this membrane or via a change of the electrical charge 
of the glomerular polyanion - a sialoprotein which covers the epi­
thelial cells on the epithelial side of the glomerular basement 
membrane (Michael et al. 1970) . It is also conceivable that re­
distribution of the renal blood flow to a nephron population with 
different permeability characteristics could be of influence in 
the effect of indomethacin on proteinuria. Some authors maintain 
that indomethacin enhances the selectivity of the proteinuria 
(Conté et al. 1970; Arisz et al. 1975, 1976), which could imply 
a change in the permeability characteristics of all nephrons to-
gether. This hypothesis has not been confirmed by .others in 
clinical (Wijdeveld 1971) or experimental situations (Daha 1973; 
Gribnau 19 75). Indomethacin does cause an abrupt decrease of the 
excretion of fibrin degeneration products in patients with glom-
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erulonephritis and proteinuria, but the authors who have describ-
ed this effect (Vermijlen et al. 1970; Clarkson et al. 1972; 
Dotremont et al. 1973; Michielsen et al. 1976) explain it as a 
consequence of diminished deposition of fibrin in the glomeruli 
and not, surprisingly, as an expression of decreased glomerular 
permeability to these molecules during indomethacin medication. 
It might be that the abovementioned second and third explana-
tions of the effect of indomethacin on proteinuria should be com-
bined. The permeability characteristics of the glomerular membrane 
are dependent, not only on the structure and the electrical charge 
of the membrane but also on haemodynamic factors (Arturson et al. 
1971; Lambert et al. 1971, 1972; Du Bois et al. 1975; Chang et al. 
1975; Ryan et al. 1976). 
It seemed to us that a systematic study of the effects of indo-
methacin on parameters of glomerular permeability is a good ap-
proach to face these unsolved problems. Determination of fraction-
al macromolecule clearances seemed the most attractive method. For 
this purpose we selected polydisperse polyvinylpyrrolidone (PVP). 
The investigations of Hulme and Hardwicke (1966, 1968; et al. 
1972) have supplied good information on the permeability to PVP 
in normal individuals and patients v/ith proteinuria due to various 
125 causes. Unlike dextran infusions, the small amounts of I-label-
led PVP used do not influence the circulating blood volume. It 
seemed worthwhile to study the findings obtained from fractional 
PVP clearances in relation to the effects on the so-called differ-
ential clearance of natural proteins observed in the patients ex-
amined. Of course the results of the investigation into effects 
on glomerular permeability should be considered as a whole against 
the background of the effects of indomethacin on proteinuria and 
glomerular filtration. The problem statement of this study there-
fore is as follows. 
1. Does indomethacin have an effect on glomerular permeability 
measured from fractional clearances of polydisperse polyvinyl-
pyrrolidone in patients with a nephrotic syndrome? 
2. Does indomethacin have an effect on the differential clearance 
of natural proteins in patients with a nephrotic syndrome? 
12 
3. How are effects (if any) on glomerular permeability related 
to effects on proteinuria and glomerular filtration rate? 
13 
Chapter II 
SOME DATA ON GLOMERULAR PERMEABILITY 
The production of urine begins with a process of ultrafiltra-
tion of plasma through the so-called glomerular membrane - a sim-
plified term for the structurally complex septum between the lumen 
of the glomerular capillaries and the capsular space. The process 
of ultrafiltration is possible because the hydrostatic pressure 
in the glomerular capillary exceeds the colloid-osmotic pressure 
of the plasma. There is a striking difference between glomerular 
capillaries and other capillary systems in the organism. Whereas 
elsewhere in the pericapillary circulation there is a balance be-
tween the amount of "plasma water" leaving on the arteriolar side 
and the amount returning on the venous side, a net loss of "plas-
ma water" develops in the glomerular capillaries which is only 
partly compensated by reabsorption in the postglomerular peri-
tubular capillaries. This net loss of "plasma water", or ultra-
filtrate, provides the basic fluid for urine production. The dif-
ference is largely based on the relatively high permeability of 
the glomerular membrane, and partly also on hydrostatic pressures 
in the glomerular capillaries. Another consequence of the permea-
bility characteristics of the glomerular membrane is that only 
low concentrations of macromolecular substances are transferred 
from the blood stream to the capsular space. 
The only information available on the permeability characteris-
tics of the human glomerular membrane is indirect information ob-
tained by extrapolation of data fron animal experiments and from 
total effects measurable in the human organism. On the basis of 
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studies in mammals (Wirz 1956; Gottschalk and Hylle 1956; Selkurt 
et al. 1965; Gertz et al. 1966) it was assumed until recently 
that the mean hydrostatic pressure in the human glomerular capil­
laries (Pgc) should be about 65 mmHg, while the pressure in the 
capsular space (Pc) should be 15 mmHg (Renkin and Gilmore 1973) . 
More recent studies by Brenner et al. (1971, 1972) in Munich-
VJistar rats have shown, however, that at least in these animals 
the Pgc is 60 cm H2O, while the Pc is 14 cm HjO. This is more in 
agreement with theoretical calculations (Landis and Pappenheimer 
1963; Arturson et al. 1971; Lambert et al. 1972). Accepting a 
colloid-osmotic pressure of 25 mmHg in arterial plasma and a fil­
tration fraction (GFR/RPF) of 0.20, the mean hydrostatic pressure 
(Pgc) in the human subject can be estimated to be 30 mmHg or about 
40 cm H2O. The interaction of these forces is known to produce a 
mean glomerular filtration rate (GFR) of 125 ml/min. 
Now, if 
GFR = K f (Pgc - Pc - Пдс), 
in which Kf is the ultrafiltration coefficient (the measure of 
the permeability of the glomerular membrane to water and substanc­
es dissolved in it), then this coefficient can be estimated with 
the aid of the above data to be 6-12 ml/min/mmHg or, given a mean 
2 
glomerular filtration surface of 0.8 m for the two human kidneys, 
2 
8-16 ml/min/mmHg/m (Renkin and Robinson 1974). The high permea­
bility of the glomerular membrane is apparent from the fact that 
this ultrafiltration coefficient is at least ten times that of 
the intestinal capillaries, and at least 50-100 times that of mam­
malian muscle capillaries (Zweifach and Intaglietta 1968). It is 
evident that the inhibitory effect of an increase in colloid-os­
motic pressure on the process of ultrafiltration is far more narked 
in the glomerular capillaries than in other capillary beds, where 
the decrease in hydrostatic pressure to below the colloid-osmotic 
pressure causes the ultrafiltrate leaving on the arteriolar side 
to return to the vascular bed on the venous side. 
The already mentioned investigations by Brenner et al. have 
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shown, not only that the hydrostatic pressure in the glomerular 
capillaries is relatively low but also that the relatively high 
ultrafiltration coefficient (Kf) for these capillaries remains 
virtually constant during variations in glomerular plasma flow 
(Deen et al. 1973). The effective filtration pressure (hydrostat­
ic pressure minus colloid-osmotic pressure) at the afferent end 
of the glomerular capillary proves to be largely independent of 
the glomerular blood flow during variation of the latter from sub­
normal to more than twice the normal value. Within the same varia­
tion in glomerular blood flow, hydrostatic and colloid-osmotic 
pressure always prove to be in balance at the efferent end of the 
capillary. Moreover, the filtration fraction proves to be inde­
pendent of the glomerular plasma flow. These findings have led to 
the conclusion that glomerular ultrafiltration must be a plasma 
flow dependent process. The explanation should lie in the profile 
of the pressure gradient between the afferent and the efferent 
end of the glomerular capillary. Given a low plasma flow (Qp), the 
effective filtration pressure along the capillary will decrease 
quickly to zero, as a consequence, not of an appreciable decline 
in the transcapillary hydraulic pressure difference (ΔΡ) but rather 
of a progressive increase in the colloid osmotic pressure dif­
ference (ΔΠ). In other words ΔΠ rises to a value which, on average, 
exactly equals ΔΡ. This equality of ΔΠ and ΔΡ is referred to as 
filtration pressure equilibrium. An increase in plasma flow will 
shift the point of filtration pressure equilibrium along the cap­
illary to the efferent end. Even higher values of Од will cause 
disequilibrium with a decrease in single nephron filtration frac­
tion (SNFF). As long as filtration pressure equilibrium is main­
tained, anywhere along the capillary, SNFr is predicted to remain 
constant and single nephron glomerular filtration rate (SNGFR) 
will vary in a linear fashion with Q A. 
So far, the permeability of the glomerular membrane has been 
considered exclusively as a process of ultrafiltration, i.e. as a 
bulk flow of water and the constituents dissolved in it. Another 
factor of importance is the permeability to larger molecules 
transported across the membrane largely by diffusion. Efforts have 
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been made to formulate the process of diffusion in terms of pore 
models, in which factors as molecular radius and steric and frac-
tional hindrance in the pores play a role (Pappenheimer et al. 
1951). Other efforts have focused on thermodynamic equations, 
based on the assumption that the amount of a substance which passes 
the glomerular capillary wall per unit of time from blood compart-
ment to urine compartment, is proportional to the product of the 
concentration of that substance in the blood compartment, the 
gradient of the chemical potential of that substance over the mem-
brane, and the surface area over which diffusion takes place 
(Chinard 1952) . Other thermodynamic formulations describe the 
interaction between solution and solvent, solution and membrane, 
and solvent and membrane (Kedem and Katchalsky 1958) . Both equa-
tions with pore models and those which obey thermodynamic laws 
have proved useful in theoretical calculations of permeability 
characteristics to macromolecules. The differences between the 
two approaches have proved less marked than they were initially 
thought to be (Lambert et al. 1972; Chang et al. 1975). The de-
velopment of gel filtration has pointed out that the pore theory 
may well be applicable to the glomerular membrane. The latter 
functions as a hydrated gel in which molecules diffuse under a 
restriction which increases with molecular radius. This theory 
(already advanced by Chinard) has been corroborated in experiments 
involving gel chromatography of basement membrane material (Huang 
et al. 1967), and also in morphological studies with tracer mole-
cules of different radii (Farquhar 1975) . Further elucidation was 
achieved in studies of the urinary excretion of substances with 
known molecular radius and electrical charge. Substances with a 
molecular weight up to 15.000 and a molecular radius of about 22 
A are now known to appear in the glomerular filtrate in the same 
concentration as in plasma (Brewer 1951; Wallenius ]Q54; Arturson 
and Wallenius 1964; Hulme and Hardwicke 1968). The glomerular mem-
brane is as permeable to substances up to this siz^ as to water. 
Albumin (molecular weight 69.000, radius 36 8) appears in the 
glomerular filtrate only in small quantities; the glomerular mem-
brane, therefore, is hardly permeable to this substance. Research 
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into permeability to macronolecular substances has been done with 
proteins as well as with metabolically indifferent polydisperse 
substances such as dextran and polyvinylpyrrolidone. The last-
mentioned substances have distinct advantages because they pass 
the tubular system virtually unaffected (unlike proteins, which 
are partly re-absorbed), and because they have no electrical charge. 
Consequently their filtrate:plasma ratio is a measure of their 
relative clearance. Their clearance can be calculated as a frac-
tion of the clearance of metabolically indifferent low molecular 
weight substances which reflects the GFR. Actually, the ratio 
between the concentrations of these substances in urine and in 
plasma, expressed as percentage of the same concentration ratio 
of low molecular weight substances, indicates their clearance as 
perecentage of GFR. This is briefly indicated as "relative clear-
ance" . 
The permeability to proteins and polydisperse substances has 
been studied (for the proteins with correction of proximal re-
absorption) via the filtrate:plasma ratio in correlation with mo-
lecular weight and radius. Figure 1 presents a survey of the data 
obtained, after Renkin and Robinson (1974). This figure warrants 
two conclusions. First, the filtrate:plasna ratio decreases with 
increasing molecular radius, and the results of dextran and PVP 
clearances coincide when the effective molecular radius is taken 
as parameter. Secondly, permeability to proteins proves to be less 
than would correspond with their molecular radius. Permea-
bility of proteins reaches zero at an effective molecular radius 
above 36 A, while the end-point of permeability to uncharged 
polydisperöe substances is 50-55 A. Apart from the porosity and 
the shape of the molecules, therefore, the electrical charge 
evidently plays a role. This assumption has been confirmed in re-
cent studies on single nephrons in which the fractional clearances 
of albumin were compared with those of uncharged dextran and the 
anion polymer dextran sulphate, the dextrans having been selected 
so, that their molecular radii equalled those of albumin. Dextran 
sulphate behaved like albumin, and the filtraterplasraa ratio of 
these two substances was only 5% of that of uncharged dextran 
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Fig. 1. Glomerular permeability to macromolecules in the adult mammalian kid­
ney. The top figure shows the filtrate:plasma ratios on the basis of molecular 
weight, and the bottom figure shows these ratios on the basis of molecular 
radius (after Henkln and Robinson 1974). 
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(Bennett et al. 1976; Chang et al. 1975, 1976). These findings 
would seem to indicate that the glomerular polyanion acts as a 
barrier to proteins. In rats with nephrotoxic nephritis, the per­
meability to dextran sulphate was found to be increased, whereas 
that to neutral dextran was decreased. 
Considerable research has been done concerning the question 
whether morphological methods could provide some insight into the 
permeability characteristics of the glomerular membrane. The wall 
of the glomerular capillaries consists of several layers and dif­
fers in many ways from that of other capillaries. Λ schematic re­
presentation is shown in figure 2, modified after Latta (1973). 
3000 -. 
5000 A 
3200 A 
I-
500-1000 A 
Fig. 2. Schematic representation of the wall of the glomerular capillary 
(after Latta 1973). 
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The inner layer consists of fenestrated endothelium, the pores 
of which (at least in man) are not lined with a diaphragm. The 
pores have a diameter of 500-1000 A. The next layer is the base­
ment membrane which consists of three sublayers: from the inside 
out, the low-density lamina rara interna followed by the micro­
fibrillar lamina densa and the low-density lamina rara externa. 
The human basement membrane totals about 3200 A and consists of 
about 60% collagen and 40% glycoproteins (Misra and Beman 1966, 
1968). Unlike other capillaries, the glomerular wall has an outer 
lining which consists, not of an adventitia of connective tissue 
but of a structurally complex layer of visceral epithelial cells, 
often called podocytes. It is assumed that these podocytes are 
packed close together in vivo (Graham and Karnovsky 1966; Latta 
1970). The fact that in conventional electron-optical micrographs 
these processes are far apart, is probably due to shrinkage of 
the material during fixation. The podycytes are embedded in the 
lamina rara externa at intervals of about 240 A, and the areas in 
between are lined with a so-called slit membrane v/hich has a 
thickness of 40-60 8. The space betv/een the epithelial cell pro­
cesses is occupied by the polysaccharide coats of the epithelial 
cell walls, which touch each other. The height of the epithelial 
cells and podocytes is 3000-5000 Й. The superficial membranes of 
the epithelial cells and the podocytes are covered by a layer of 
100-150 A thickness: the glycocalix, which consists of acid nuco-
polysaccharides with numerous anion groups (Michael et al. 1970). 
There is no consensus about the relative contributions of the 
various layers of the glomerular basement membrane to the filtra­
tion barrier (Farquhar 1975). A first barrier is thought to be 
made up of a layer of large serum proteins along the endothelial 
side of the basement membrane and in the lamina rara interna. 
These proteins form a negatively charged layer which can penetrate 
through the basement membrane into the Bowman space whenever the 
intrarenal circulation is interrupted, temporarily or permanently 
(Ryan et al. 1976). The lamina densa has been described as a second 
barrier (Farquhar 1975) , and a third barrier exists at the level 
of the slit membrane (Venkatachalam et al. 1970) . A final barrier 
21 
is formed by the glomerular polyanion which extends over the epi­
thelial cells (Michael et al. 1970). 
Since about 1960, the passage through these structures of the 
glomerular membrane has been studied with the aid of electron-
dense or histochemically detectable substances, on the assumption 
that the critical barrier could be indicated by accumulation of 
the substance in question in the glomerular wall, and that subse­
quently the tracer properties would warrant conclusions about the 
nature of the barrier. With electron-dense tracers such as ferri­
tin (molecular radius 61 R), thorotrast (molecular radius 100 A) 
and polydisperse colloidal gold (molecular radius 20-100 8), it 
was found that the lamina densa acts as a filter which selects on 
the basis of molecular radius and thus constitutes a barrier to 
substances with a molecular radius of more than 60-100 8. Histo­
chemically detectable tracers such as horseradish peroxidase 
(molecular radius 30 A) and myeloperoxidase (molecular radius 44 
A) proved to pass the lamina densa but then to accumulate at the 
level of the slit membrane between the podocytes. On the basis of 
this finding it has been assumed that, on the filter of the lamina 
densa, on the epithelial side at the level of the slit membrane, 
there could be a finer-pore filter as a barrier to molecules with 
an effective radius of 35-50 A (Graham and Karnovsky 1966). In 
recent years, however, this so-called double filter theory has 
been refuted on the basis of research with dextrans rendered 
electron-dense by conjugation to osmium and lead, with molecular 
radii of 38-78 Й. These prove to be capable of diffuse penetra­
tion of the basement membrane at a rate which decreases with the 
molecular radius, and without accumulation at the level of the 
slit membrane (Caulfield and Farquhar 1974). The positively charg­
ed alkaline molecules myeloperoxidase and horseradish peroxidase, 
however, are restricted to the strongly negatively charged layer 
which covers epithelial cells and slit membrane: the glomerular 
polyanion. The relatively small acid molecule cytochrome С (mole­
cular radius 15 A) passes unrestricted - either by its radius or 
by its charge - through the entire membrane. The function of the 
slit membrane and the podocytes on the epithelial side of the 
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basement membrane has not herewith been explained. There are indi­
cations that the epithelium synthesizes basement membrane mate­
rial (Kurtz and Feldman 1962) and re-absorbs proteins which have 
passed (Caulfield et al. 1975). The structure and the electrical 
charge of the glomerular basement membrane, therefore, are fac­
tors which partly determine the permeability characteristics for 
macronolecules. Ryan's study, already mentioned, demonstrated the 
plausibility of an effect of changes in intrarenal circulation on 
permeability to macromolecules. With improved fixation techniques 
it has been established that the permeability to IgG and catalase 
increases during interruption of this circulation. The abovemen-
tioned studies with tracer molecules must now be revised because 
their results were obtained with preparations fixed in a situation 
of interrupted circulation. 
In the process of ultrafiltration, the glomerular plasma flow 
proves to be of importance. In the process of diffusion, largely 
responsible for the permeability to macromolecules (Chinard 1952; 
Arturson et al. 1971; Lambert et al. 1972), haemodynamic factors 
likewise play a role. According to theoretical model studies (Du 
Bois et al. 1975) , the shape of the permeability curve for macro­
molecules is determined by the following factors: pore radius (r), 
integrated mean effective filtration pressure (GFP), gradient of 
hydrostatic intracapillary pressure (e), protein concentration of 
arterial plasma (p) and filtration fraction (TF). If an increase 
in pore radius is selected, the whole permeability slope shifts 
lateral to a larger molecular radius. The slope of the permeabili­
ty characteristics is influenced mainly by the GFP, in such a way 
that - at a given constant FF - a lower value of GFP causes the 
permeability to increase, whereas at a higher GFP the permeability 
to macromolecules up to 37 A decreases. At a constant GFP, a de­
crease in FF causes a slight shift in the permeability characteris­
tics to a smaller molecular radius, whereas an increase in FF 
causes a slight shift to a larger radius. If both GFP and FF are 
constant, then the effect of e proves to be only minimal. A lower 
value for ε causes a slight increase in permeability. In a model 
with a constant r, the permeability to macromolecules can be in-
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fluenced especially via GFP and FF: an increase in GFP and a de­
crease in FF lead to decreased perireability to macromolecules. 
The Brenner group, who demonstrated the plasma flow dependence 
of GFR, used different terns for the factors which influence per­
meability to macromolecules. They replaced the term GFP by glom­
erular plasma flow (Од); other terms they used were: transcapillary 
hydrostatic pressure gradient (ΔΡ), colloid-osnotic pressure of 
the system (ΠΑ), and glomerular ultrafiltration coefficient (Kf). 
These are the same factors as above mentioned in the determina­
tion of glomerular ultrafiltration. They calculated that an in­
crease in Q A had to lead to a decreased permeability to macro­
molecules. Indeed the fractional clearances of dextran molecules 
prove to decrease with an increase in glomerular plasma flow, and 
vice versa (Chang et al. 1975). This means that a reduction in the 
transcapillary pressure gradient leads to increased permeability 
to macromolecules, in agreement with the theoretical calculations 
already mentioned. The processes of ultrafiltration and diffusion, 
therefore, are dependent on glomerular plasma flow, or the trans­
capillary pressure gradient. The larger this glomerular plasma 
flow, and the later the zero value of the pressure gradient in 
the glomerular capillary is reached, the larger the amount of ul­
trafiltrate but the lower the permeability to macromolecules and 
the clearance of fractions of these molecules. In other words : 
at a low plasma flow rate, diffusion of macromolecules can occur 
over a large area in the glomerular capillary, while at a high 
plasma flow rate the zero value of the transcapillary pressure 
gradient in the glomerular capillary is reached later, so that 
ultrafiltration is promoted. 
The glomerular plasma flow is regulated and influenced by a 
large number of factors. Partly because of this, results of inves­
tigations in this respect are often difficult to interpret. Many 
investigators have concluded that variations in the resistance of 
the afferent arterioles is the principal factor which determines 
the renal circulation and the GFR. The variation in the resistance 
of the efferent arterioles is likewise of influence, but this va­
riation is less marked. Moreover, the contribution of the efferent 
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arterioles to total resistance is believed to be slightly greater 
than that of the afferent arterioles because the former, fixed at 
rest, have a higher tonus (Renkin and Robinson 1974). The resis-
tance in the peritubular capillaries is correlated to the local 
colloid-osmotic pressure and, therefore, to the filtration frac-
tion and the other factors which determine RPF and GFR. The 
mechanism of autoregulation seems to be localized in the afferent 
arterioles. Without going into detail, it can be stated that reno-
vascular resistance is regulated by myogenic receptors, which are 
influenced by neurogenic factors, circulating catecholamines, the 
renin-angiotensin system, the prostaglandins and possibly the 
kinins. The renin-angiotensin system and the prostaglandins are 
probably the most important (Itskowitch and McGiff 1974; Zins 1975). 
Another facet of intrarenal and glomerular blood flow concerns 
the distribution over the nephron population. Different species of 
mammals show anatomical differences between the superficial cort-
ical and juxtamedullary glomeruli; the latter are larger and have 
longer tubular systems. In rodents, an additional mid-cortical 
type of nephron can be distinguished (Baines and De Rouffignac 
1969). The GFR per nephron proved to be lower in the superficial 
than in the juxtamedullary nephrons, although disparate values 
were found in mice, rats and Psammomys obesus (Hansen 1961; Baines 
and De Rouffignac 1969). In rats on a sodium-restricted diet, fil-
tration in the superficial cortical nephrons proved to be lower 
than that in the juxtamedullary nephrons; but on a high-sodiun 
intake the reverse was observed (Horster and Thurau 1968) . Cal-
culations of the mean glomerular capillary hydrostatic pressure 
have shown that in situations of volume expansion this is higher 
in the superficial nephrons, whereas on a sodium-restricted diet 
it is higher in the juxtamedullary nephrons (Renkin and Gilmore 
1973). A high sodium intake apparently leads to a decreased re-
sistance in the arterioles of the superficial glomeruli, resulting 
in a shift of intrarenal circulation to cortical nephrons without 
any change in the ultimate amount of filtrate. Whether the per-
meability characteristics of superficial cortical glomeruli differ 
from those of juxtamedullary glomeruli has so far remained unde-
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cided. With the above data in mind, however, it is quite concei-
vable that a difference between the glomerular plasma flow in 
juxtamedullary glomeruli and that in cortical glomeruli leads to 
a difference in permeability to macromolecules in spite of an 
otherwise equal factor for both types of glomeruli. 
In summary it can be stated that, as compared with other capil-
laries, glomerular capillaries have a much higher permeability to 
water and low molecular weight solutes. Consequently, the pressure 
gradient over the length of the glomerular capillary can be large-
ly independent of the glomerular plasma flow. At lower values of 
plasma flow, the balance between hydrostatic and colloid-osmotic 
pressure or filtration equilibrium, is reached earlier than at a 
higher flow rate. The amount of ultrafiltrate can thus vary with 
the plasma flow without changes in the permeability of the glo-
merular membrane. It is virtually certain that the glomerular 
membrane has the properties of a hydrated gel in which larger mol-
ecules can diffuse along a concentration gradient with increasing 
restriction as the effective molecular radius increases. Apart 
from the molecular radius, other properties such as in particular 
the electrical charge, are of importance for permeability to dif-
fusing molecules. A factor of great importance in this respect is 
the strong negative charge of the glomerular polyanion, localized 
on the epithelial side of the membrane that repels negatively 
charged molecules such as albumin, which in solution functions as 
a polyanion, and the anion polymer dextran sulphate. This charge 
affords at least a qualitative explanation of the fact that per-
meability to natural proteins and dextran sulphate is limited to 
an effective molecular radius of 35 8, whereas that to uncharged 
molecules such as PVP and dextran is limited to an effective mol-
ecular radius of 50 A. Destruction of this polyanion structure 
could result in increased permeability to natural proteins. 
Finally, haemodynamic factors prove to play a role also in dif-
fusion of macromolecules. Specifically, the permeability to macro-
molecules decreases as plasma flow increases and vice versa. In 
situations where filtration equilibrium is not obtained due to a 
high plasma flow rate the SNFF will decrease and so does macro-
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molecular permeability. If this phenomenon, registrateci in single 
nephron studies could be applied to the total intrarenal blood 
flow a decrease in FF would indicate a further decrease in macro-
molecular permeability. These data show that glomerular permeabi-
lity is a complex property, subject to multiple regulation. 
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Chapter III 
MEASUREMENT OF GLOMERULAR PERMEABILITY TO FRACTIONAL CLEARANCES 
OF 125I LABELLED POLYDISPERSE POLYVINYLPYRROLIDONE 
DATA FROM THE LITERATURE 
In this study glomerular permeability was detemined from the 
fractional clearances of polydisperse polyvinylpyrrolidone (PVP). 
The method was introduced in 1966 by Hulme and Hardwicke, who used 
PVP labelled with radioactive iodine (Cordon 1959) and the tech-
nique of gel filtration developed between 1959 and 1966 (Porath 
and Flodin 1959; Andrews 1963; Porath 1963; Laurent and Killander 
1964; Ackers 1964; Determan and Michel 1966). PVP consists of 
polymers of vinylpyrrolidone. The polymerization produces molecules 
of various lengths. In the Forties, PVP was prepared as plasma 
substitute (Hecht and Weese 1943) but, owing to its relatively 
small molecules and consequent rapid renal excretion, it is less 
suitable for this purpose than dextrans and preparations on a 
gelatin basis. PVP has a great affinity for iodine, and can there-
fore readily be labelled with iodine isotopes. 
The literature shows that PVP can be stored in the reticulo-
endothelial system, liver, spleen, kidneys, lungs and heart (Hüssel-
mann 1952; Tothill 1965; Hulme et al. 1968). Side effects have only 
been described after massive doses (Grünfeld et al. 1968). The 
amounts used in permeability studies are only a few milligrarañes, 
and side effects can therefore be regarded as excluded. The ra-
diation dosage from the iodine isotope will be discussed in detail 
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in chapter IV. 
The fractions of PVP, and also of dextran, with molecular 
weights up to about 15000 and molecular radii up to 22 A, cross 
the glomerular membrane, as readily as creatinine (Brewer 1951; 
Wallenius 1954; Arturson 1961; Hulme and Hardwicke 1968). PVP be-
haves like dextran, has no electrical charge and is not reabsorbed 
in the tubular system or excreted (Wallenius 1950, 1954; Hardwicke 
et al. 1968; Renkin and Robinson 1974) ; the clearance of the above-
mentioned fractions therefore reflects GFR. The clearances of the 
separate fractions can be calculated after intravenous administra-
tion of polydisperse PVP, followed by fractional gel filtration 
according to molecular size of samples of serum and urine. In all 
cases the U:P ratio per fraction is determined and expressed as 
percentage of the low molecular weight fractions, and therefore 
as percentage of GFR. 
The technique of gel filtration also nakes it possible to cal-
culate the molecular radius of the fraction in question. Earlier 
studies have revealed a sigmoid relation between penetrable gel 
volume fraction and molecular radius (Laurent and Killander 1964) , 
but also a negative linear correlation between penetrable gel 
volume fraction and the logarithm of the molecular radius (Ackers 
1964; Andrews 1965). For Sephadex G200, this can be expressed in 
the equation 
log Rs = 0.871 + 1.085 (1-Kav), 
in which 
Rs = Einstein Stokes radius of the molecule concerned 
Kav = penetrable gel volume fraction. 
For Sephadex G200 this correlation is valid over the molecular 
radius range from 15 to 80 8, or a 1-Kav range from' 0.30 to 0.95. 
This permeability to macromolecular fractions shows a sigmoid 
curve if the clearance percentage GFR is plotted against the loga-
rithm of the molecular radius in accordance with the equation for 
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the permeability of an isoporous membrane (Pappenheimer et al. 
1951). For normal human kidneys, this curve is exactly followed 
up to 70% of GFR clearance. Above this value, the clearance per-
centages of these smaller fractions prove to be higher than pre-
dicted (Hulme et al. 196 8; Arturson et al. 1971) . Calculations 
with substitution of various possibilities, resulted in a two-
pore model with a pore distribution of 10.000 small pores (mean 
size 25.5 + 2 A) on one large pore of 41 + 13 A (Arturson et al. 
1971; Lamert et al. 1972). The sigmoid relation between clearance 
percentage GFR and molecular radius indicates a normal distribu-
tion of pores. 
PVP clearance (e/o GFR) 
100-
-r 
43 65 28 34 53 
molecular radius(A) 
Fig. 3. The sigmoid relationship between clearance percentage GFR and molecular 
radius in a normal test subject. 
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The sigmoid relationship is shown in figure 3, in which the 
molecular radius has not been linearly plotted on the X-axis but 
in accordance with the equation log Rs = χ + y (1-K
a v
), as already 
mentioned for Sephadex G200 and as will be further elaborated for 
our test method. Probit transformation of the clearance percentage 
GFR results in a linear correlation (Finney 1962) . The advantage 
of this linearity is that regression lines can be calculated by 
the least squares method and the relations established can be ma­
thematically described in simple terms and compared with each other 
(cf figure 4) . 
PVP clearance ( 0/o GFR) 
99.9-
99-
90 
70-
50 H 
30 
10-
1-
01-
V/ 1 1 1 ! 1 1 r 
1Θ 22 28 34 43 53 65 
о 
molecular radius (A) 
Fig. 4. Probit transformation of the clearance percentage GFR, plotted against 
molecular radius, of the data in figure 3. 
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Hardwicke et al. (1968) published the results of permeability 
studies with PVP in rabbits, while Hulme and Hardwicke (1968) 
reported on such studies in normal human subjects and patients 
with glomerulonephritis. The described regression line proved to 
exist both for rabbits and for human individuals, the difference 
being that in rabbits the slope extends more to the right, indi-
cating higher permeability. In patients with glomerulonephritis 
they found three types of regression line: a normal and two de-
viant types. 
As figure 5 shows, the authors found permeability slopes of the 
type observed in normal subjects, but also slopes showing an in-
creased permeability to molecules larger than 40 8; and besides 
increased permeability to molecules larger than 40 A, decreased 
permeability to molecules smaller than 40 8 also proved to occur. 
The authors attempted to establish a correlation between the type 
of permeability characteristics and the pathological 
findings in renal biopsy specimens from their patients. However, 
they failed to reach definite conclusions. Later, Hardwicke (1972) 
tried to explain the various types of permeability slopes. A nor-
mal permeability slope, despite proteinuria, in his opinion im-
plied either a normal pore structure but changes in effective 
filtration pressure and total filtration surface, or a slight in-
crease in pore size. Permeability slopes with only an increased 
clearance percentage of molecules larger than 40 A, would indi-
cate that part of the basement membrane had larger pores or was 
damaged. Permeability slopes with a reduced clearance percentage 
of molecules smaller than 40 8 and an increased clearance percen-
tage of the fractions larger than 40 A, would indicate partial 
damage and thickening of the basement membrane. At the same time, 
however, he suggested that minor haemodynamic changes in the cap-
illaries might exert an influence on the permeability to macro-
molecules. In only four of the seven patients studied by PVP 
clearances as well as protein fraction clearances did these authors 
find a fair correlation between the permeability characteristics 
obtained by the two methods. 
Other investigators also used macromolecules in the study of 
glomerular permeability, alone or in comparison with the relative 
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Clearance С/« GFR ) 
99-
20 30 50 70 100 
molecular radius (Re A) 
Fig. 5. The three types of permeability slopes to PVP molecules as encountered 
in patients with glomerulonephritis (after Hulme and Hardwicke 1968). 
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clearances of natural proteins. In three out of twelve patients 
with proteinuria, Gassêe et al. (1967) found no correlation between 
the regression line obtained with PVP clearances and that obtained 
with protein fraction clearances. Four patients showed an excellent 
correlation, and the remaining five showed a fair correlation. 
Using fractional dextran clearances, Pétrie et al. (1968) did find 
a good correlation with protein fraction clearances in patients 
with minimal lesions and membranous glomerulonephritis, but a much 
less good correlation in patients with proliferative glomerulo-
nephritis. Mogensen (1968) determined dextran clearances in nine 
healthy adults, in four of whom twice. His findings agreed with 
those of the other authors. Arturson et al. (1971) believed that 
the differences in permeability between macronolecular clearances 
and protein clearances (which differences they did not identify 
more exactly) are based on differences in electrical charge and 
shape of the molecules. Arisz (1969, 1973) failed to find a good 
correlation between immunologically determined selectivity indices 
of IgG and transferrin on the one hand, and selectivity indices 
determined with PVP fractions with a molecular weight of 160.000 
and 40.000, on the other. Robson et al. (1974) determined PVP 
clearances in six normal children and sixteen children with mini-
mal change nephrotic syndrome. In these children the permeability 
to molecules larger than 40 8 was normal, but there was a decreased 
relative clearance of smaller molecules, which returned to normal 
when the proteinuria and oedemas disappeared in response to cor-
ticosteroid therapy. 
In summary: the literature shows that patients with a glomeru-
lar lesion can show a permeability slope of a normal type for 
macromolecules as PVP and dextrans, but also an increased permea-
bility to these molecules larger than 40 A, alone or in combina-
tion with decreased permeability to molecules smaller than 40 A. 
Virtually all investigators who made comparative studies of the 
relative clearances of macromolecules on the one hand and those 
of natural proteins on the other, have reported that they did not 
always find good correlations between the permeability characteris-
tics obtained by the two methods. It must be assumed that differ-
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enees in shape and electrical charge between natural proteins and 
the macromolecules used are responsible for these discrepancies. 
The less high accuracy of the relative protein fraction clearances 
may also have played a role in this respect. 
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Chapter IV 
FRACTIONAL CLEARANCE OF POLYVINYLPYRROLIDONE 
METHODS AND PATIENTS 
125I-labelled PVP. 
Fractional PVP clearances were performed using polydisperse 
125 
PVP labelled with I. This was supplied as a pyrogen-free, ste-
rile, isotonic solution in succinate buffer with 1% benzyl alco-
hol (Radiochemical Centre, Amersham, England). The amount of PVP 
in these solutions averaged 1.39 mg/ml (range 0.86-3.4 mg/ml). 
The radioactivity was stated to be 50 uCi/ml. The manufacturer 
always added to the PVP solution Amberlite IPJV 400 as ion ex-
changer in order to trap free radioactive iodine. Determination 
125 
of the residual I activity in this ion exchanger always yielded 
values fron 26 to 38 gCi. According to the manufacturer, the ion 
125 
exchanger kept the free I concentration below 1%. This was con-
firmed by Hazenberg (1968) in dialysis experiments. Arisz (1973), 
however, found an average of 7% free I or I in urine from 
his patients and controls. This percentage is of no relevance to 
the results with our method because we use relative clear-
ances of fractions, and free iodine either appears in the final 
fractions of eluate as micromolecular substance, or it is bound to 
macromolecular proteins and does not penetrate in the gel but ap-
pears in the eluate at the start of the filtration process. 
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Gel filtration. 
The column characteristic in gel filtration is determined by 
the negative linear correlation between the logarithm of molecul-
ar radius and elution volume, as indicated in chapter III. The re-
levant data can be summarized as follows. 
For the passage of molecules through cellulose membranes it can 
be stated (Ferry 1936) that: 
A = Ao (1 - J ) 2 , (1) 
in which: 
A = effective area of the pore 
Ao = total cross-sectional area of the pore 
a = molecular radius 
r = pore radius 
Taking into account the combined effects of steric hindrance to 
the molecule when entering the pore, and frictional hindrance at 
its passage through the pore, total restriction in diffusion can 
be expressed as follows (Renkin 1955): 
~íb = (l " f)2 [ 1 ' 2 · 1 0 4 Φ + 2 · 0 9 (f )3 " 0 · 9 5 (f )5 ] (2) 
For molecular sieve chromatography columns which consist of granu­
lar agar or dextran gels, the equation can be extended (Ackers 
1964) to: 
2|=Ϊ2 = (i - ¿ ) 2 r ι - 2.104 (f) +2.09 ( | ) 3 - 0.95 (f) 5 ] (3) 
i n w h i c h : 
Ve = elution volume 
Vo = void volume, or volume of water in the column 
Vi = volume of free solvent in the gel phase. 
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According to Laurent-Killander (1964) : 
_ Ve - Vo . 
к
а - vt - Vo ' l 4 } 
K
a v
 = elution constant 
in which: 
K
a « 
Vt = total volume of the column. 
Since, per definition, 
Vi = Vt - Vo, (5) 
combination of the equations (3), (4) and (5) gives: 
K
av = (1 - f ) 2 [l - 2.104 (|) + 2.09 (J)3 - 0.95 (f)5] (6) 
This equation indicates the relation between molecular radius and 
elution constant at a given pore size in the gel. Once pore size 
r is found with molecules of known radius a, the radius of unknown 
molecules can be calculated from the elution pattern. In a random 
gel there is a negative linear correlation between the logarithm 
of molecular radius and the elution constant (Ackers 1964; Laurent 
and Killander 1964; Andrews 1965; Determann and Michel 1966). 
This relation can be expressed as: 
log Rs = χ + y (1 - K
a v
) , (7) 
in which: 
Rs = Einstein-Stokes radius of the molecule 
K
a v
 = elution constant 
χ = intercept of the straight line 
y = slope of the straight line. 
For Biogel A 5 M, which contains 6% agarose, this correlation was 
demonstrated by Fish et al. (1969). The Biogel A 0.5 M used by us 
contains a larger percentage of agarose: about 10%; its elution 
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pattern is virtually the same as that of Sephadex G200. The manu­
facturer indicates a linear correlation between elution constant 
and molecular weight in the range from smaller than 10.000 to 
500.000. For Biogel A 0.5 M, the relation between elution constant 
and molecular weight and molecular radius first had to be esta­
blished. 
Gel filtration was performed using a 70 χ 2.6 cm column (type 
К 26/70 by Pharmacia, Uppsala, Sweden) with flow adaptors. Vie 
used a 10% agarose gel (Biogel A 0.5 M, 200-400 mesh, by Bio-Rad 
Laboratories, Richmond Cal., USA). The stability of this gel ex­
ceeds that of Sephadex G200. Once poured, a column can be used 
for weeks or months, without variance in volume, in spite of the 
relatively high flow (30 ml/hr) we used. Moreover, a slightly 
sharper separation is achieved than with Sephadex G200. Biogel A 
is supplied fully hydrated by the manufacturer; the suspension 
fluid contains 0.0 2% sodium azid, 0.001 M tris and 0.001 M EDTA. 
Once poured, the column is rinsed with an elution fluid for at 
least 24 hours. As eluent we always used a buffer solution of 0.1 
M tris and 0.2 M NaCl in distilled water, with 1 ml 20% sodium 
azid added per liter solution as preservative. The acidity of the 
eluent was set at pll 8.0 with 1 N HCl. The column was perfused 
with eluent from top to bottom at a constant flow of 30 ml/hr, en­
sured by a Cenco 12-channel peristaltic pump placed behind the 
column. The pouring of a new column was always followed by a test 
separation with 2 m] human serum in order to establish the pattern 
of elution. 
A Uvicord II (LKB) was used for continuous measurement of the ex­
tinction of the eluate at 280 run. The results were recorded on an 
LKB recorder. The eluate was collected in fractions of 2.5 ml with 
the aid of a fraction collector type Ultrarac 7000 (LKB). The 
column was characterized with the aid of a number of substances of 
known molecular weight, as shown in table I. 
When on a logarithmic scale the molecular weights are plotted 
against the elution volume (Ve), one obtains a virtually linear 
relation between Ve and log molecular weight 12.500-480.000, as 
indicated in figure 6. The Einstein-Stokes radius of cytochrome С 
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TABLE I 
Charaoteristio Pharmacia column К 25/60 with 
Biogel A 0.5 M 200-400 mesh 
α-crystallin 
DND alanin 
ferritin 
catalase 
aldolase 
bovine albumin 
ovalbumin 
chymotrypsinogen 
cytochrome С 
Molecular 
weight 
800.000 
345 
480.000 
240.000 
147.000 
67.000 
45.000 
25.000 
12.400 
Stokes radius 
in 8 
36.1 (b) 
23.4 (a) 
22.4 (a) 
16.4 (a) 
Ve in ml 
85 
282 
87 
142 
150 
160 
177 
215 
233 
K
av 
Vo 
Vt 
0.01 
0.30 
0.33 
0.38 
0.47 
0.66 
0.75 
(a) = Laurent-Killander (1964) 
(b) = Ackers (1964) 
is 16.4 8 (Laurent and Killander 1 9 6 4 ) , while that of bovine al­
bumin is 36.1 A (Ackers 19 6 4 ) . By introducing the Einstein-Stokes 
radii of cytochrome С and bovine albumin, equation (7) can be re­
solved; it is then found that χ = 0.9833 and у = 0.9262 so that 
the relation which applies to the gel column used by us is: 
log Rs = 0.9833 + 0.9262 ( 1 - K
a v
) . 
This characteristic therefore applies to a molecular weight range 
of 12.500-480.000 or a radius of 16.4-79.5 P. This is in agree­
ment with data from the literature for Sephadex G200, giving a 
range of 15-80 8 (Ackers 1964; Laurent and Killander 19 6 4 ) . 
Table II lists the calculated Einstein-Stokes radii as related to 
the elution constant in accordance with the equation which applies 
to Biogel A 0.5 M 200-400 mesh. The column characteristic there-
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Ve (m I) 
300-
250-
200 
150-
100-
5 0 -
DND alanine 
• cytochrome-С 
hymotrypsmogen 
spvalbumin 
^bovine albumin 
"-•aldolase 
. · catalase 
^ferrit in 
-·— 
crystallm 
,— 1—ι— 1—ι— ι 1 1—ι ι 
IO3 IO4 105 IO6 
molecular weight 
-Fig. 6. Negative correlation between elution volume (Ve) and molecular weight 
plotted on a logarithmic scale, as obtained with the data from table I. 
fore limits the measurement of molecular radii to the range from 
16.4 to 79.5 8, corresponding with a K
a v
 value of 0.75-0.01. 
Consecutive runs proved to show only slight differences in elu­
tion volume for a particular molecular size, because Vo and Vt 
also vary remaining K
a v
 virtually constant. Fish et al. (1969) 
found a variation of 1.3% for cytochrome C, but they used weight 
instead of volume for the terms Vo, Ve and Vt. Calculations in 
terms of volume revealed a standard deviation of + 3% (Davison 
1968). 
Table III lists the K
a v
 values for albumin and IgG in six con­
secutive runs over the same column, with their means and standard 
deviations in percents, in terras of volume. The variation for IgG 
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TABLE I I 
Correlation between (Ι-Κ^) value and Rs in Д, calculated in accor­
dance with the equation log Из = 0.9833 + 0.9262 ГЗ-К J 
1-K. Rs Molecule 
0.25 
0.30 
0.40 
0.50 
0.60 
0.63 
0.70 
0.74 
0.80 
0.85 
0.90 
0.99 
16.4 
18.2 
22.6 
28.0 
34.6 
36.8 
42.9 
46.6 
53.1 
59.0 
65.6 
79.5 
cytochrome С 
albumin (bovine) 
IgG (human) 
TABLE III 
Variation of K
a0 for albumin and IgG in six consecutive 
runs with the same sample 
Protein Mean K
av
+SD 
albumin 
IgG 
0.3684 
0.3684 
0.3684 
0.3579 
0.3637 
0.3637 
0.2526 
0.2526 
0.2526 
0.2653 
0.2737 
0.2737 
0.3663+1.2% 
0.2618+4* 
proves to be slightly greater than that for albumin, but is in 
agreement with data from the literature. Columns of different 
samples of Biogel did differ in K_„ values for albumin and IgG. 
Values found for albumin ranged from 0.344 to 0.42, and those for 
IgG ranged from 0.244 to 0.32. Whenever the К values differed 
from the means as listed in table III, the regression lines ob­
tained were corrected accordingly. In all cases 2 ml serum was 
transferred from the test subject to the column, or 1 ml urine 
supplemented with 1 ml normal human serum. This made it possible 
to register, for urine samples also, an extinction pattern with a 
peak for albumin and IgG, required for determination of the column 
characteristic and for control (or correction) of the elution 
pattern. Using the K
a v
 values registered at each run, the plasma 
and urine fractions were correlated as optimally as possible. 
Serum and urine samples of a PVP clearance were always transfer­
red to the column in consecutive runs, but only once per 24 hours. 
If possible, the same column was used for all determinations in 
one patient. All procedures were carried out at a constant tempera­
ture of 220C. 
Measurement of radioactivity. 
The fractions collected were counted in a γ-sample counter 
(LKB-Wallac 60.000) during five minutes. All fractions from just 
before Vo to nearly at Vt were counted, a total of 90 fractions 
per run. In every run, three blank tubes were counted as well in 
order to measure the background activity in the system. The mean 
background activity was calculated from these tubes, and then 
automatically subtracted by the counter from the number of counts 
per 5 minutes. 
Figure 7 shows that the distribution of activity over the various 
125 
fractions after gel filtration of 0.15 yCi I-labelled PVP com­
bined with 1 ml human serum for determination of K
a v
, shows virt­
ually the same pattern as a sample 5 minutes after injection of 
125 1 yCi I-labelled PVP per kg body weight, taken from the same 
ampoule and administered to a test subject. It can be concluded 
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Fig. 7. Distribution of radioactivity over the various fractions after gel 
125 
filtration of 0.15 pCi I-labelled PVP combined with 2 ml pooled human 
serum (top) and of serum from the test subject. 
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Fig. 8. The elution pattern of two consecutive plasma samples (PI = o-o; 
P2 = x-x) and distribution of PVP in the urine during the same clearance 
period (U = ·-·). 
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from these figures that a homogeneous distribution of PVP existed 
in the blood circulation of the test subject after 5 minutes. 
Bearing in mind that there is a systematic decrease in activi­
ty in consecutive fractions, the error was not determined with the 
aid of the Poisson distribution for each separate measurement, 
but calculated upon the mean of the measurements for each plasma 
sample (PI and P2) and for the urine sample (U). The error upon 
the mean was 1.3% for PI, 1.7% for P2 and 0.4% for U in the test 
subject. In accordance with the law on progression of errors, the 
combined error in the radioactivity count after calculation of 
U:P ratios is: 
-V^T e2 2 + e3 2 = 2.2S 
U/P ratio 
100 tube № 
Pig. 9. U:P ratios plotted per fraction number. 
Vo = tube 42; Vt = tube 140 
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Radioactivity in the consecutive serum fractions showed an ex­
ponential course in time, for each equivalent fraction as correct­
ed for its K
a v
. The logarithmic mean of two consecutive plasma 
fractions was used in calculating the U:P ratio for each fraction. 
Figure 8 presents radioactivity per fraction in a plasma sample 
at the start and at the end of a one-hour clearance period (PI and 
P2), with the corresponding distribution of radioactivity over the 
fractions in the urine of the same clearance period. The initial 
peak is produced by Vo: the macromolecular substances which pass 
through the column outside the gel phase. As the molecules become 
smaller (more to the right in the figure)., the activity of PVP in 
the urine increases. It is evident that with the decreasing mole­
cular radius of PVP, increasing U:P ratios are calculated until 
a limit is reached. It is shown in figure 9 that the limit of the 
U:P ratios is here reached at tube 99-10 3, i.e. at a К of 
0.70-0.74. According to table II (page 42), these are molecules 
with a Stokes radius of 16-18 A, which have a clearance equal to 
GFR. 
Radiation dosage. 
The radiation dosage to which a test subject is exposed when 
125 
an isotope is used, merits more detailed attention. I is a 
γ-radiation emitter with a half-life of 60 days and an energy of 
0.027 MeV. 
Tothill (1965) calculated a radiation dosage for the liver of 
0.05 rad/uCi for I, but he assumed that all PVP not excreted 
by the kidneys was stored in the liver. Hulme et al. (1968) made 
extensive studies of radiation dosages on the basis of data publ­
ished by Ravin et al. (1952) and Meyer (1962), which showed that 
PVP is stored also in the spleen. Dependent on molecular size, 
they found exponential disappearance curves for various PVP frac­
tions from the plasma. After 100 hours the total plasma activity 
had decreased to less than 1% of the dose administered, although 
only 45% activity was recovered in the urine. In the human organ­
ism, 50% of the PVP fraction with average molecular weight 38.000 
and 40% of that with average molecular weight 32.000 was still 
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present. As expected, the fraction with molecular weight 12.500 
was no longer demonstrable. In rats, the corresponding rates were 
lower (44% and 38%, respectively) due to a different permeability 
characteristic of the rat glomerular membrane. Examination of the 
rats after 5 days revealed that 5% of the activity was stored in 
the liver and 1.7% in the spleen. In mice, considerable activity 
was found also in the lymph nodes and the thymus. Moreover, the 
activity in the spleen after 4 weeks proved to be four times that 
after 2 days, while in the liver the activity after 4 weeks was 
three times that after 2 days. Calculation of the radiation dosage 
for an organ is therefore difficult. Hulme concluded that the 
plasma half-life is 12 hours, and that subsequently 5% of the ac-
tivity is stored in the liver. He calculated a radiation dosage 
for the liver of 0.013 rad/uCi 125I-labelled PVP. 
Arisz (1973), studying normal test subjects, found a plasma 
half-life of 9 hours for low-molecular PVP and one of 17 hours for 
high-molecular PVP. In patients with proteinuria the corresponding 
half-life values were 11 and 18 hours, respectively. In Wistar 
rats, Arisz found storage of activity especially in the liver, 
spleen and lymph nodes. Less activity was found in the lungs, heart 
and thymus; very little activity was found in the kidneys, and 
even less in the skeletal muscles. He, too, observed an increase 
in activity in liver and spleen as measured 2 and 7 days after 
administration of the isotope, but after 14 days the activity in 
these organs was slightly less again. For macromolecular PVP he 
125 
calculated a radiation dosage for the liver of 1 rad/25 wCi I-
labelled PVP. 
The above data can be used to approximate the radiation dosage 
for a patient, assuming that storage in liver and spleen is of the 
same order of magnitude in rats and human subjects. For a patient 
with a body weight of 70 kg, with a liver of 1500 g and a spleen 
of 150 g, the dose administered should be 70 yCi. After 5 days, 
5% of this dose is stored in the liver, and 1.7% in the spleen. 
Disregarding the radiation of the isotope initially circulating 
in the plasma as well as a possible increase of storage in organs 
with increasing time, it can be maintained that: 
48 
Ι η , -. Eef f χ Ac D = 2.13 χ , 
m 
in which: 
D = dose rate in rad/hour 
Eeff = energy absorbed in the organ per disintegration in MeV 
Ac = number of \iCi present in the organ 
m = organ mass in grammes. 
It can also be maintained that: 
D t x Teff 
D œ = ^ — « 
0.693 
in which: 
D » = total dose in the organ 
Teff = effective half-life in hours. 
The effective half-life is dependent on the biological and physi-
cal half-life. Assuming that the PVP, once stored, remains in the 
organ, the effective half-life equals the physical half-life. In 
125 that case it can be maintained for I-labelled PVP that: 
Teff = Tphys = 60 days. 
For the liver it can then be maintained that: 
A -,-,-, 0 .027 χ 70 χ 0.05 „
 n r > r > , , . , ,, 
D = 2 . 1 3 χ i q n n = O · 0 0 0 1 · 3 4 r a d / h o u r 
n
 0.000134 χ 60 χ 2 4
 n
 _Q , D
 - = ÖT693 0 · 2 8 r a d· 
For the spleen it can be maintained that: 
' _ .. ., 0 . 0 2 7 χ 70 χ 0 . 0 1 7
 n Л П
о
Л
с
С
 J / u 
D = 2 . 1 3 χ τ-ξΤΓ = 0 . 0 0 0 4 5 5 r a d / h o u r . 
0 . 0 0 0 4 5 5 χ 60 χ 24 .
 o c
 , D - = д - ^ з = 0 . 9 5 r a d . 
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After administration of a dose of 70 uCi and with a plasma half-
life of 12 hours, the whole-body radiation dosage of the initial­
ly circulating I-labelled PVP is: 
„ ,, 70 χ 0.027 11.9 „ „, ·, 
D
"
 2
·
1 3 X
 70.000 X ÏÏT693 = 0 · 0 1 r a ä· 
In our experimental set-up the test subject is twice given 70 yCi, 
and the above calculations must therefore be multiplied by factor 2. 
125 For the radiation from I, and absorbed dose of 1 rad corresponds 
with a radiation dosage of 1 rem. The maximum tolerable annual 
dose for the entire human body has been set at 5 rem for radio-
logical workers, and at 0.5 rem for members of the general public. 
In organs such as liver and spleen this dose may be three times 
as large. 
Clinical procedure. 
All patients were given 180 mg potassium iodide daily from 3 
125 days before the first injection of I-labelled PVP to 8 days 
after the second injection; this was done in order to prevent up-
take of radioactive iodine into the thyroid. One hour before PVP 
injection the test subjects were given 1000 ml water to drink. 
The bladder was emptied as thoroughly as possible immediately be-
fore the injection. Blood samples were collected 5, 60 and 120 
125 
minutes after injection of 1 цСі I-labelled PVP per kg body 
weight. The first sample was taken from the arm not used for the 
PVP injection so that a reliable distribution over the circulating 
blood volume seems plausible. A few minutes after collection of 
the second and the third blood sample, the test subject was asked 
to empty the bladder as thoroughly as possible. Two consecutive 
one-hour clearances were thus carried out. All urine was collected. 
No catheters were used. Vfhenever a second PVP clearance was done, 
the PVP injection was preceded by collection of a blood sample for 
verification of possible residual activity of the previously injec­
ted PVP. In the patients, the first PVP clearance w^s performed 
without medication and the second one after 5 days of medication 
50 
with 3 χ 50 mg indonethacin daily. Every day, 24-hour urines were 
collected from 0300 hrs to 0800 hrs. The creatinine excretion was 
used to control urine collection, and to calculate the endogenous 
creatinine clearance. The urinary protein concentration was also 
determined per 24 hours. After chemical analysis, the urines of 
125 
the first two 24-hour periods collected after injection of It-
label led PVP were stored for controlled decay. Serum creatinine 
and protein electrophoresis were determined on day 2 and day 5 
during indomethacin medication, and also on day 2 and day 5 of 
the period without medication. 
PVP clearances in test subjects with normal renal function. 
In order to determine the permeability characteristics for PVP 
fractions in persons with normal renal function, PVP clearances 
were performed by the method described in five adult volunteers 
with normal renal function after careful instruction. In three of 
them the test was repeated after 5-7 days, so that three duplicate 
determinations were made. All test subjects had an endogenous cre­
atinine clearance of more than 100 ml/min, normal blood pressure, 
no proteinuria, no sediment changes aryî no anamnestic clues to 
any nephropathy. As mentioned in the section on "Clinical·proced-
ure", two clearances were always performed during consecutive one-
hour periods. For all fractions obtained after gel filtration in 
each clearance period, the U:P ratios were calculated as percen-
tage of the limiting value reached and therefore as percentage of 
GFR, as indicated in figure 9 (page 46). Clearance percentage GFR 
of each fraction of PVP was plotted against the corresponding 
1-Kav value using the probit transformation on the y-axis and 
linearly on the x-axis. The 1-Kav value can then be replaced by a 
corresponding molecular radius in accordance with the equation 
log Rs = 0.9Θ33 + 0.9262 (1-K
a v
). A linear regression line through 
the points obtained was then calculated. The ultimate regression 
line was determined from the mean slope and intercept of the first 
and the second one-hour clearance. Whenever the gel column charac­
teristic deviated from the values given for albumin and IgG in 
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Fig. 10. Permeability characteristics in five volunteers with normal renal 
function. 
table III (page 42 ) , the regression line was corrected to these 
values in order to ensure comparability of the results. As shown 
in figure 10 and table IV, the differences between the regression 
lines obtained were small, particularly for molecules smaller than 
30 A. The separate regression lines were always calculated from 
29-40 points, and proved to have a high coefficient of correlation. 
Starting from this high coefficient of correlation for the separate 
regression lines, a mean regression line can be calculated with 
the 95% confidence limits. If the regression line drawn in figure 
11 were extended to the x-axis, it would cross the x-axis at 
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TABLE IV 
Regression lines representing the permeability aharaateristio 
for PVP in five controls with normal renal function 
(r - - 0.988 to - 0.996). 
y = 29.02 - 35.55 χ 
y = 25.83 - 28.11 χ 
y = 26.25 - 29.61 χ 
y = 28.84 - 34.33 χ 
y = 26.53 - 30.01 χ 
P V P clearance С/. GFR) 
95 
34 43 53 
m o l e c u l a r radius (A) 
F i g . 11. Mean regres s ion l i n e with 95% confidence l i m i t s in f ive c o n t r o l s 
with normal r e n a l function (y = 27.29 - 31.52 x ) . 
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1-Kav = 0.865, which corresponds with a molecular radius of 60 A. 
Molecules larger than 60 A are therefore not excreted in the urine. 
This finding corroborates the data from the literature (Hulme and 
Hardwicke 1968; Gassee et al. 1968; Mogensen 1968; Arturson et al. 
1971; Robson et al. 1974). 
Reliability of the method. 
Molecules with a radius greater than 53 A, corresponding with 
a 1-Kav value of 0.8 and higher, occur only in small quantities 
or are absent from the urine; consequently the accuracy of the 
U:P values in this range is relatively low, due to inaccuracy in 
the measurement of U. On the other side of the regression line 
obtained, the clearance of molecules with a radius of 18 A virtu-
ally equals that of creatinine (Brewer 1951; Wallenius 1954) or 
inulin (Robson et al. 1974). These small molecules, therefore, 
quickly disappear from the plasma and consequently reliability 
diminishes in this range, too, due to inaccuracy in the measure-
ment of P. Moreover, the limit of the separating capacity of the 
gel used is reached in this range, as mentioned in the section 
"Gel filtration". In the macromolecular range above 53 A the re-
liability of the determination is influenced, not only by the ex-
ceedingly low radioactivity in the urine fractions but also by 
retention of radioactivity in the column. In order to gain insight 
into this matter, two experiments were performed. 
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For the first experiment, 18 pCi I-labelled PVP was supple-
mented with 1 ml pooled human serum and transferred to the column. 
Under standard conditions, 200 fractions of eluate were collected 
which were all counted in the y-sample counter. The next day, 2 ml 
human serum was transferred to the column and another 200 fractions 
of eluate were collected and counted. It is shown in figure 12 
that, in the fractions after Vt, a certain but decreasing amount 
of radioactivity still appears. Line (200+) can be regarded as 
the continuation of line (0+), because consecutive fractions of 
eluate are involved. The void volume (Vo) of the gel column proves 
to contain only little radioactivity the next day, but when the 
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Fig. 12. Distribution of radioactivity over 400 consecutive fractions after transfer of 
125 18 vCi I-labelled PVP with 1 ml human serum to the column (fractions 1-200), followed 
125 the next day by transfer of 2 ml human serum without added I-labelled PVP (fractions 201-400) . 
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transferred serum begins to appear in the fractions the radio-
activity increases again, and virtually parallels the line of the 
125 PVP fractions. This suggests that the I retained in the column 
- free or bound to PVP or to agarose - shows an affinity for the 
protein molecules. The figure indicates that, in the range from 
125 tube 110 to Vt, the activity of I-labelled PVP amounts to 
3000-5000 counts per second. The next day the activity of the 
eluate fractions is 15-50 counts per second. Particularly in the 
low molecular weight range this can lead to an error of measure-
ment of about 2%. In the range from tube 50 through tube 110, the 
values are 8000-11000 counts per second, and on the next day they 
are 50-80 counts per second; in this range, therefore, the error 
remains below 1%. 
During this study, some activity was regularly found in the 
urine fractions in the macromolecular range 1-Kav 0.90-0.99, ex-
ceeding that in range 1-Kav 0.8-0.9. In view of this an experi-
ment was carried out in which the normal working situation was 
125 
imitated. First 2 ml human serum to which 0.15 viCi I-labelled 
PVP had been added, was transferred to the column. The eluate of 
200 fractions was tested for radioactivity during 5 minutes. The 
125 
next day, 1 ml urine and 1 ml serum without I activity was 
transferred to the column, and again 200 fractions were counted 
during 5 minutes. The results are shown in figure 13. Again, 
radioactivity was still measurable in the fractions after Vt, and 
this activity increased in the fractions from Vo to Vt of the urine 
sample transferred the next day. The residual activity (40-90 
counts per minute) exerts no influence on the urine determinations 
in the molecular range with a low 1-K_,T value, because in that 
av 
range the activity is high, as shown in figure 8 (page 45). In the 
macromolecular range, however, and especially above a 1-Kav value 
of 0.8, few if any excreted PVP molecules are present. As the 
figure shows, the first eight fractions after Vo even contain more 
activity than the subsequent fractions. The consequence is that 
the U:P ratio and the percentage limiting U:P cannot be reliably 
determined in the range 1-Kav 0.90-0.99, although the separating 
capacity of the gel is still linear, as shown in section "Gel-
filtration". For all these reasons, the mean regression line was 
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Fig. 13. Distribution of radioactivity over 400 consecutive fractions after transfer of 2 ml human serum with 
125 0.15 yCi I-labelled PVP to the column (fractions 1-200), followed the next day by transfer of 1 ml urine 
125 
with 1 ml human serum, without added I-labelled PVP (fractions 201-400). 
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determined in controls with normal renal function for molecular 
radii of 22-53 8, with the confidence interval valid for this 
range. In three controls the PVP clearance was repeated one week 
after the first experiment. The results are presented in figure 14. 
PVP clearance (»/„GFR) 1 
95 
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F i g . 14. Permeabi l i ty s lope for PVP in t h r e e c o n t r o l s , determined in d u p l i c a t e 
with an i n t e r v a l of one week. The continuous and i n t e r r u p t e d l i n e s of the same 
type r e f e r t o the same c o n t r o l . 
These dupl ica te determinations were used t o c a l c u l a t e the d u p l i ­
cate e r r o r . The dupl ica te e r ror was 5.2% on the i n t e r c e p t and 8.4% 
on the s lope. The v a r i a t i o n in the slope of the permeabil i ty 
c h a r a c t e r i s t i c therefore apparently exceeds t h a t in the i n t e r c e p t . 
I t i s poss ib le t h a t these di f ferences are a t l e a s t p a r t l y caused 
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by a variation in the elution volume of a single fraction, i.e. 
2.5 ml IgG or albumin during the various runs, which results from 
the fact that the albumin as well as the IgG fraction is often 
distributed over two tubes in gel filtration. In all cases 
efforts were made to ensure the best possible correlation between 
plasma and urine fractions. A shift in urine fractions by two 
tubes in relation to the corresponding plasma fractions can lead 
to an error of bias of 8.7% or -4.0%, respectively (Pétrie et al. 
1968). 
In the patients to be discussed in the next section, the limit 
of the U:P ratio was sometimes not reached. In those cases ever-
increasing values for U:P were calculated. Comparison with figure 
9 (page 46) shows that in those cases the line therefore continued 
to rise and did not reach a horizontal level. This phenomenon, 
although described by several authors, has not so far been ade-
quately explained. 
Wallenius (1954) and Arturson et al. (1966) assumed that micro-
molecular dextran is distributed over the interstitial space re-
sulting in a rapid fall of plasma levels in individuals with oede-
ma. Hulme and Hardwicke (1968) suggested that failure to reach a 
limit might be explained by an inadequate dose of PVP administered. 
This explanation is improbable in view of the radioactivity in 
the fractions of the first serum sample collected 5 minutes after 
injection of PVP in those of our patients who showed this phenom-
enon. Arisz (1973) found that the concentration of low molecular 
weight PVP in serum from patients with a nephrotic syndrome, 10 
minutes after injection, exceeded that in normal test subjects -
suggesting a reduced circulating volume in patients with a nephro-
tic syndrome. This observation argues against the theory advanced 
by Wallenius and Arturson et al. 
Failure to reach a limit for U:P may be based on a relatively in-
creased clearance of low molecular weight fractions. This would 
have to be interpreted as markedly decreased permeability to PVP 
molecules smaller than 40 A to about 22 Й, with continued normal 
permeability to the smallest PVP fractions, which are cleared only 
via ultrafiltration. 
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Patients examined. 
In 28 patients with a nephrotic syndrome, PVP clearances were 
determined before and during indomethacin medication. Regression 
lines could be calculated in 24 patients; in the remaining four, 
no limit of the U:P value was reached. These four were not in­
cluded in the evaluation of results. As in the controls, the mean 
of the regression lines obtained in the first and the second one-
hour clearance period was calculated. All the regression lines 
calculated, for the first and for the second one-hour clearance 
period, had a high coefficient of correlation (-0.990 or higher) 
and this is therefore not mentioned separately. In the patients 
with an increased clearance of PVP molecules larger than 40 л, 
the regression line for molecules smaller than 40 A was calcula­
ted. In these cases we calculated for the fractions larger than 
40 8 the clearance percentage GFR for every fraction. Means of 
these clearance percentages without and during indomethacin were 
compared. A survey of the 28 patients is presented in table V. 
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TABLE V 
Some data on 28 patients in whom fractional PVP alearanaes were determined 
before and during indmethaoin medication 
Patient Age in Sex Diagnosis 
number years 
membranoproliferative glomerulonephritis 
membranoproliferative glomerulonephritis 
amyloidosis 
amyloidosis 
amyloidosis 
focal segmental glomerulonephritis lupus erythematosus 
cellular and humoral rejection 
membranoproliferative glomerulonephritis 
focal segmental glomerulonephritis 
cellular and humoral rejection 
mesangial proliferative glomerulonephritis 
membranoproliferative glomerulonephritis 
epimembranous glomerulonephritis 
segmental proliferative glomerulonephritis 
focal segmental glomerulonephritis 
intracapillary glomerulonephritis 
focal glomerulonephritis 
focal segmental glomerulonephritis 
membranoproliferative glomerulonephritis 
focal segmental glomerulonephritis 
focal segmental glomerulonephritis 
humoral rejection 
focal segmental glomerulonephritis 
epimembranous glomerulonephritis 
minimal lesions 
focal segmental glomerulonephritis 
focal segmental glomerulonephritis 
proliferative glomerulonephritis 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
19 
24 
70 
44 
71 
32 
58 
28 
26 
28 
21 
27 
40 
72 
28 
29 
45 
27 
25 
43 
18 
30 
21 
44 
44 
26 
47 
40 
f 
m 
f 
f 
m 
f 
m 
f 
m 
m 
f 
m 
m 
m 
m 
f 
m 
m 
m 
m 
f 
m 
f 
m 
m 
m 
f 
f 
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Chapter V 
PVP CLEARANCES IN PATIENTS WITH A NEPHROTIC SYNDROME 
WITHOUT AND DURING INDOI^ETHACIN MEDICATION 
Results. 
In 24 of the 28 patients, permeability slopes could be calcu-
lated which revealed the three types described by Hulme and Hard-
wicke (cf figure 5, page 33). In patients 25 through 28 of table V 
no limit was reached for the U:P values in the low molecular weight 
range. The permeability slopes in patients 1 through 3 of table V 
proved to be like those found in individuals with normal renal 
function. Figure 15 shows that there is virtually no difference 
between the permeability slopes without and during indonethacin 
medication in these patients. Table VI lists the regression lines 
of figure 15, along with the pathological diagnosis and the data 
on endogenous creatinine clearance, proteinuria and serum albumin 
concentration. The regression lines for the three patients hardly 
differ without and during indomethacin medication. The endogenous 
creatinine clearance decreased during indomethacin medication in 
patients 1 and 3, and remained constant in patient 2. Each of the 
three patients showed an unmistakable effect on proteinuria. In 
patient 3, the clearance of PVP molecules smaller than 30 A was 
slightly decreased in relation to the confidence limits in normal 
controls. This phenomenon occurred both without and during indome-
thacin medication. 
The second group of patients (numbers 4 through 8 of table V) 
consists of five patients who showed normal permeability to PVP 
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Fig. 15. Permeability slopes for PVP in three patients, without and during 
indomethacin medication (normal type). 
molecules smaller than 40 8, but increased relative clearance of 
PVP molecules larger than 40 8. As figure 16 shows, there was no 
difference in the permeability slopes of these patients for PVP 
molecules up to 40 8 without and during indomethacin medication. 
However, the clearance percentage GFR for molecules larger than 
40 8 was lower during indomethacin medication, as clearly demon­
strated by the data in table VII. This table shows ^ nce again that 
the regression lines of these five patients did not essentially 
differ without and during indomethacin medication. In four of the 
five patients, however, the mean clearance of molecules larger than 
40 A was significantly lower during indomethacin medication, and 
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TABLE VI 
Patients with normal type permeability characteristics for PVP 
Patient 
number 
1 
2 
3 
Diagnosis 
menibranoprolif erative 
glomerulonephritis 
membranoproliferative 
glomerulonephritis 
amyloidosis with 
paraproteinaemia 
Indu­
rne thacin 
no 
yes 
no 
yes 
no 
yes 
Linear regression 
У 
У 
У 
У 
У 
Y 
= 
= 
= 
= 
= 
= 
26.81-31.Збх 
27.28-32.57х 
28.15-35.63х 
27.26-33.39х 
23.62-26.54х 
23.61-27.ОЗх 
ЕСС 
ml/min 
107 
64 
75 
75 
73 
63 
Proteinuria 
g/24 hrs 
4.8 
1.6 
7.8 
5.5 
5.2 
2.4 
Serum albumin 
g/i 
35.8 
38.5 
30.9 
31.8 
17.1 
18.4 
PVP clearance 
C/o GFR) 
18 22 28 34 43 53 65 
molecular radius (A) 
Fig. 16. Permeability slopes in five patients without and during indomethacin 
medication (normal permeability to molecules smaller than 40 A; increased per-
meability to molecules larger than 40 A). 
i n p a t i e n t 4 t h e i n c r e a s e d p e r m e a b i l i t y t o t h e s e molecu les even 
d i s a p p e a r e d c o m p l e t e l y . In p a t i e n t 6 , i n c r e a s e d p e r m e a b i l i t y t o 
molecu les l a r g e r than 40 8 was r e g i s t e r e d du r ing indomethac in medi-
c a t i o n . Th i s t a b l e a l s o shows t h a t none of t h e p a t i e n t s in t h i s 
group had a d e c r e a s e i n endogenous c r e a t i n i n e c l e a r a n c e du r ing 
indomethac in m e d i c a t i o n . In each of t h e f i v e p a t i e n t s , however, 
t h e p r o t e i n u r i a d e c r e a s e d d u r i n g m e d i c a t i o n , and in four of t he 
f i v e p a t i e n t s t h e serum albumin l e v e l r o s e du r ing t h i s p e r i o d . 
The t h i r d group c o n s i s t s of t he remain ing 16 p a t i e n t s , numbers 
9 th rough 24 of t a b l e V. A l l t h e s e p a t i e n t s showed a dec rea sed 
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TABLE VII 
Patients with normal permeability to PVP molecules up to 40 A 
and inareased permeability to PVP moteaules larger than 40 A 
Patient Diagnosis Indo- Linear regression Clearance % GFR ECC Proteinuria Serum albumin 
number methacin of PVP > 40 A ml/min g/24 hrs g/1 
Mean + SD 
amyloidosis 
amyloidosis 
focal segmental 
glomerulonephritis 
cellular and humoral 
rejection 
membranoproliferative 
glomerulonephritis 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
27.94-31. бх 
26.05-29. 8х 
29.25-35.60х 
30.04-35.89х 
27.44-32.22х 
27.13-32.22х 
28.64-34.50х 
29.79-35.59х 
25.01-27.87х 
25.20-28.09х 
0.32 
2.33 
0.71 
0.24 
1.12 
4.34 
1.43 
5.57 
0.56 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0.22 
1.17 
1.03 
0.06 
0.04 
2.18 
0.77 
3.29 
0.13 
85 
88 
45 
42 
118 
120 
34 
34 
88 
86 
7.3 
4.5 
17.5 
8.7 
4.8 
1.6 
7.0 
3.4 
3.2 
1.9 
19.0 
20.6 
17.4 
19.3 
35.8 
38.5 
23.7 
27.0 
39.5 
39.5 
relative clearance of molecules smaller than 40 8, but for mole­
cular range 22-40 8 a regression line with a high coefficient of 
correlation could be calculated. All these patients showed in­
creased permeability to PVP molecules larger than 40 8. The data 
on pathological diagnosis, endogenous creatinine clearance, pro­
teinuria and serum albumin level are listed in table VIII along 
with the data on the linear regression lines and the mean clear­
ance percentages GFR for molecules larger than 40 8. Figure 17 
and table VIII show that this group of patients likewise had the 
PVP clearance 
(·/. GFR) 
18 22 28 34 43 53 65 18 22 28 34 43 53 65 
о 
molecular radius (A) 
Fig. 17. Permeability slopes for PVP molecules in 16 patients, without and 
during indomethacin medication (decreased permeability to molecules smaller 
than 40 Д; increased permeability to molecules larger than 40 R). 
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TABLE Vili 
Patienta with decreased permeability to PVP molecules up to 40 A 
and increased permeability to PVP molecules larger than 40 A 
Patient Diagnosis 
nuraber 
Indo- Linear regression Clearance % GFR ECC Proteinuria Serum albumin 
methacin of PVP > 40 A ml/min g/24 hrs g/1 
Mean + SD 
9 focal and segmental no 
glomerulonephritis yes 
10 cellular and humoral no 
rejection yes 
11 mesangial prolifera- no 
tive glomerulonephr. yes 
12 membranoproliferative no 
glomerulonephritis yes 
13 epimembranous no 
glomerulonephritis yes 
14 segmental prolifera- no 
tive glomerulonephr. yes 
15 focal and segmental no 
glomerulonephritis yes 
y = 25.41-30.29x 
y = 25.76-30.91x 
y = 25.12-29.I7x 
y = 27.24-23.52x 
y = 25.94-32.73x 
y = 27.56-34.41x 
y = 24.00-26.67x 
y = 23.84-28.41x 
y = 23.53-27.ЗЗх 
y = 21.78-24.83x 
y = 22.41-27.29x 
y = 21.61-26.29x 
y = 23.07-25.43x 
y = 21.73-23.33x 
0.29 
0.42 
1.44 
1.16 
+ 
+_ 
+ 
+ 
0.289+ 
0.136+ 
1.23 
0.32 
1.13 
0.08 
0.25 
0.06 
2.68 
0.87 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
0.22 
0.17 
0.93 
0.90 
0.446 
0.084 
0.34 
0.15 
0.69 
0.09 
0.21 
0.04 
1.10 
0.22 
68 
65 
44 
40 
95 
53 
110 
85 
95 
90 
90 
49 
54 
8.2 
2.8 
5.8 
3.6 
9.5 
1.5 
3.4 
7.6 
5.7 
9.2 
1.2 
13.8 
5.4 
34.9 
36.9 
29.9 
31.3 
33.5 
39.2 
25.8 
18.5 
22.9 
38.9 
34.4 
8.8 
14.2 
Continuation 
Patient 
number 
16 
17 
18 
19 
20 
21 
22 
23 
24 
Diagnosis 
intracapillary 
glomerulonephritis 
focal glomerulo­
nephritis 
focal and segmental 
glomerulonephritis 
membranoproliferative 
glomerulonephritis 
focal and segmental 
glomerulonephritis 
focal and segmental 
glomerulonephritis 
humoral rejection of 
kidney transplant 
focal and segmental 
glomerulonephritis 
epimembranous 
glomerulonephritis 
Indo-
methacin 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
no 
yes 
Linear regression 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
= 
21.50-25.00х 
22.10-26.50х 
22.53-27.83х 
23.00-28.38х 
25.70-31.85х 
25.82-32.05х 
21.70-23.94х 
23.60-27.00х 
18.62-20.68х 
21.30-23.68х 
23.94-23.86х 
25.76-29.66х 
22.83-24.ЗЗх 
21.19-24.86 
21.89-23.91х 
23.36-26.89х 
17.05-17.50х 
19.60-19.56х 
Clearance % GFR 
of PVP 
Mean 
5.53 
1.80 
0.38 
0.16 
1.51 
0.79 
0.82 
1.39 
1.22 
0.43 
0.34 
0.03 
0.62 
0.28 
0.08 
0.64 
+ 
+ 
+ 
+ 
+ 
+ 
0 
+ 
+ 
+ 
+ 
+ 
0 
+ 
+ 
+ 
+ 
+ 
+ 
> 40 8 
SD 
0.86 
1.08 
0.20 
0.09 
0.66 
0.44 
0.46 
0.38 
0.62 
0.14 
0.23 
0.02 
0.22 
0.21 
0.03 
0.09 
ECC 
ml/min 
75 
24 
133 
95 
96 
94 
H O 
78 
40 
32 
55 
45 
89 
83 
54 
43 
48 
48 
Proteinuria 
g/24 hrs 
12.1 
7.9 
5.5 
1.9 
6.3 
2.7 
10.2 
2.9 
14.1 
9.5 
8.1 
4.3 
9.6 
4.0 
8.4 
4.3 
5.3 
5.3 
Serum albumin 
g/i 
14.6 
18.8 
31.0 
32.0 
28.9 
32.7 
19.3 
29.1 
15.6 
16.5 
40.2 
38.6 
29.3 
31.9 
40.2 
38.2 
17.0 
15.9 
same permeability slopes for PVP molecules smaller than 40 A 
without and during indomethacin medication, although in some pa-
tients the variation exceeded that in the previous two groups. 
In 13 of the 16 patients, the mean clearance percentage GFR for 
PVP molecules larger than 40 Ä proved to be smaller during than 
without indomethacin medication. In two patients this percentage 
was larger (numbers 9 and 24), and in one patient (no. 19) there 
was no difference. This established effect on permeability to 
molecules larger than 40 8 is significant (p < 0.01, sign test). 
Table VIII also shows that in all patients (except no. 12 for whom 
data on the period without indomethacin are lacking) the protein-
uria decreased during medication; this decrease was usually asso-
ciated with an increase in serum albumin concentration (except in 
numbers 14, 21, 23 and 24). In 10 of the 16 patients the decrease 
in proteinuria was associated with an often slight decrease in 
endogenous creatinine clearance. The quantification of these ef-
fects, and the correlation of the effect on proteinuria to that 
on endogenous creatinine clearance, will be discussed in chapter 
VIII. 
Overall, 21 of the 24 patients in this study showed an increas-
ed relative clearance of PVP molecules larger than 40 A. During 
indomethacin medication the relative clearance of these molecules 
decreased in 17 of the 21 patients, increased in 3 patients and 
remained unchanged in one. For the entire group, too, this effect 
is significant (p < 0.01, sign test). Considering the mean clear-
ance percentages GFR for PVP molecules larger than 40 8 in these 
21 patients, without and during indomethacin medication, one finds 
the mean clearance without indomethacin to be 1.39 + 0.33% GFR 
(SEM). During indomethacin medication this value is 0.56 + 0.12% 
GFR (SEM). The difference is significant (p < 0.02, Student's 
t-test). Figure 18 once more shows the mean clearance percentage 
GFR for PVP molecules larger than 40 8 in the 21 patients with an 
increased clearance of these molecules, without and during indo-
methacin medication. In this figure, the clearance percentage GFR 
have been plotted linearly on the y-axis, and consequently the de-
crease in permeability to molecules larger than 40 A during indo-
methacin medication is expressed much more clearly than in figure 
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6-
control ndomethacm 
Fig. 18. Mean clearance percentage GFR of PVP molecules larger than 40 A in 
21 patients, without and during indomethacin medication. 
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16 and 17, where the probability scale has been applied. 
Discussion. 
The results of this study of the effects of indomethacin on 
glomerular permeability demonstrate that there is no effect on the 
relative clearance of molecules smaller than 40 A, regardless of 
whether these clearances are equal to or lower than those in nor-
mal controls. In patients presenting permeability slopes of the 
normal type, indomethacin had no effect either on the relative 
clearance of molecules larger than 40 8, up to about 50 A which 
is the limit of permeability to macromolecules. In the patients 
with an increased relative clearance of PVP molecules larger than 
40 A, this clearance showed a significant decrease during indome-
thacin medication. This effect on permeability to PVP molecules 
larger than 40 A is not directly related to a decrease in endoge-
nous creatinine clearance. In four of the five patients in group 2 
in whom this phenomenon was observed, it was not accompanied by a 
change in endogenous creatinine clearance (table VII). In 8 of the 
16 patients of the third group the endogenous creatinine clearance 
decreased. In the two patients in whom increased relative clear-
ance of PVP molecules larger than 40 A was observed during indo-
methacin medication, the endogenous creatinine clearance showed 
hardly any decrease (patient 9) or remained unchanged (patient 24). 
In patient 19, however, the endogenous creatinine clearance did 
decrease, although no effect was observed on the clearance of PVP 
molecules larger than 40 8. In all patients the proteinuria de-
creased during indomethacin medication, regardless of the type of 
permeability slopes obtained at fractional PVP clearances. The 
data indicate that the type of permeability slope found, is not 
related to the GFR as measured from endogenous creatinine clear-
ance. Nor is a correlation found between the type of permeability 
slope and the pathological diagnosis or the serum albumin level. 
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Chapter VI 
GLOMERULAR PERMEABILITY MEASURED FROM DIFFER­
ENTIAL CLEARANCE OF NATURAL PLASMA PROTEINS 
Introduction. 
An alternative research approach to glomerular permeability 
lies in the possibility of studying the nature and amount of loss 
of natural plasma proteins. This method differs in several ways 
from that which utilizes inert, foreign material. To begin with, 
properties and differences in properties such as molecular shape 
and electrical charge play a more prominent role in the natural 
proteins than in inert substances. Next, it is always to be borne 
in mind that metabolic processes - synthesis and extrarenal loss -
should be considered in the interpretation of, specifically, clear­
ance data. Particularly in the study of clearances it is of im­
portance that filtered proteins are reabsorbed by the tubular 
system via a process which is based on pinocytosis and therefore 
largely non-selective. Finally, the presence of protein loss, i.e. 
a pathological situation, is a prerequisite for the use of this 
method of investigation. 
The conventional way of measuring glomerular pemeability from 
natural proteins is determination of the so-called differential 
protein clearance. This method was introduced in 1955 by Hard-
wicke and Squire. They measured protein contents in plasma and 
urine with the aid of paper electrophoresis, and calculated the 
quotient of the clearance of γ-globulin and albumin, respectively. 
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globulin clearance 
С/« albumin clearance) 
IOD­
IO 
1-
0.1 
2.5 10 25 
molecular weight (xlO ) 
Fig. 19. Relative protein clearances in three types of histological abnorm­
alities, measured from transferrin (S), IgG, CI complement (CI), a2-macro-
globulin (a2M) and B-lipoprotein (0L). 
M = membranous glomerulonephritis 
Ρ = proliferative glomerulonephritis 
N = minimal lesions 
(after Blainey et al. 1960) 
74 
Paper electrophoresis affords only a gross approximation in the 
determination of specific proteins, and proved to yield insuffi-
ciently exact data. Only when by immunological methods of separa-
tion the determination of specific proteins had been improved 
(Gell 1957; Soothill 1962; Mancini et al. 1965) did it become pos-
sible adquately to determine the relation between molecular size 
and clearance of a protein. 
In patients with a nephrotic syndrome, Blainey et al. (1960) 
studied the clearance of a number of proteins with increasing mol-
ecular weight as percentage of albumin clearance, and established 
that clearance decreased as molecular size increased. They utiliz-
ed transferrin, IgG, CI complement, a2-macroglobulin and g-lipo-
protein assays. The course of the curve, they maintained, proved 
to be dependent on the underlying disease. 
Figure 19, derived from their publication, shows that the relation 
between the clearance of a protein measured from albumin clearance 
on the one hand, and molecular weight on the other hand, took a 
steep course in patients with minimal lesions, less steep in pa-
tients with proliferative glomerulonephritis, and least steep in 
patients with membranous glomerulonephritis. In actual fact there 
were six patients in each group. The IgG:albumin clearance ratio 
was less than 20% in the first, 20-50% in the second, and about 
50% in the third group. The authors used the term selective pro-
teinuria when the clearance ratio was less than 20%. 
Data from the literature. 
Several authors have further analysed the value of differential 
protein clearance in the diagnosis of the underlying disease in 
patients with a nephrotic syndrome. Joachim et al. (1964) found 
high selectivity in 10 out of 12 patients with membranous glomeru-
lonephritis. Chronic glomerulonephritis, however, tended towards 
low selectivity. Van der Slikke et al. (1964) found high select-
ivity in 7 out of 8 patients with minimal lesions, and invariably 
low selectivity in 14 patients with marked histological changes. 
Hitzig et al. (1965) found selective proteinuria in each of 9 
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patients with minimal lesions, but also in 3 out of 8 patients 
with membranous glomerulonephritis and in 5 out of 9 patients 
with intracapillary glomerulonephritis. In chronic glomerulonephri-
tis they found selective proteinuria in 3 out of 8 cases, but 5 
patients with acute glomerulonephritis proved to have non-selective 
proteinuria. 
Vermeer (1966) found selective proteinuria (IgG clearance < 20% 
of transferrin clearance) in 6 out of 7 patients with minimal le-
sions. In 13 patients with membranous glomerulonephritis he found 
a mean selectivity index of 26.4% (range 16 to 48.5%), while in 8 
patients with proliferative glomerulonephritis the mean selectiv-
ity index was 36.4%. Barcello and Pollak (1966) found no correla-
tion between histological changes and selectivity index in 15 pa-
tients with various abnormalities. Vere and Walduck (1966) ob-
served in two children with minimal lesions that a low selectivity 
index remained constant during development of a complete remission. 
Cameron et al. (1966, 1967, 1968) described their experience with 
a large number of patients in a series of publications. In the 
final article they reported on 222 differential protein clearances 
in children and 178 in adults. They found a good correlation be-
tween minimal lesions and high selectivity on the one hand, and 
susceptibility to glycocorticosteroids on the other. Minimal le-
sions were present in over 80% of the children, and in this group 
the steroid response was 90%. Of the adult group with minimal 
lesions, however, only 77% proved to be susceptible to glycocor-
ticosteroids, while membranous and proliferative glomerulonephri-
tis did not respond to this medication. The authors did not express 
themselves about the value of histological examination in relation 
to the steroid response, and did not evaluate complete remissions 
in the group with other than minimal lesions. 
In a number of review articles, Hardwicke et al. (1965, 1967, 1972) 
confirmed the high degree of selectivity in minimal lesions, and 
the associated favourable effect of glycocorticosteroids. Accor-
ding to these publications, membranous glomerulonephritis shows a 
low degree of selectivity - reference is made to the already 
mentioned findings reported by Blainey et al. (1960) - while pro-
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liferative glomerulonephritis is characterized by intermediate 
selectivity. 
Miller et al. (1967, 1968, 1969) concluded from the remission rate 
in 29 patients treated with steroids in combination with nitrogen 
mustard or azathioprine that selectivity correlates fairly well 
with therapeutic results, but poorly with histological findings. 
Soothill and Hendrickse (1967) were able with the aid of the se-
lectivity index to differentiate between minimal lesions and a 
nephrotic syndrome associated with quartan malaria in 16 Nigerian 
children. Braun and Merrill (1968) found a high degree of selec-
tivity in normal individuals, but they explained this by recombi-
nation of IgG fragments during urine concentrating procedures. 
A high degree of selectivity was attained within a few weeks of 
kidney transplantation, except in cases in which rejection oc-
curred or renal function was poor. Studying 26 children, Lines 
(1969) found a good response to glycocorticosteroids in those with 
selective proteinuria. Chandra et al. (1970) described a poor 
response to glycocorticosteroids in 16 out of 27 children with 
non-selective proteinuria; all but 3 of 21 children with an IgG 
clearance < 18% of albumin clearance showed a good to fair response 
to the medication. Hulme and Porter (1970) found low selectivity 
in 3 transplantation patients with recurrence of glomerulonephri-
tis. Schena et al. (1971) observed no change in selectivity index 
in a case of chronic rejection following kidney transplantation. 
Mills et al. (1973) observed a non-linear course of selectivity 
related to the logarithm of molecular weight, measured from five 
protein molecules, in 7 out of 22 children. Five of these patients 
were found to suffer from focal glomerulonephritis, one from mem-
branoproliferative glomerulonephritis, and one from Alport's syn-
drome. The discrepancy in the clearances of the individual pro-
teins proved to be based on different values for IgG. These authors 
also observed a decrease in selectivity with progression of the 
disease. 
Arisz (1973) found a high degree of selectivity in 19 out of 21 
patients with minimal lesions, i.e. an IgG clearance < 20% of 
transferrin clearance. In 9 patients with membranous glomerulo-
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nephritis the mean selectivity index was 22% (range 10 to 35%). 
Patients with focal glomerulosclerosis and proliferative glomerulo-
nephritis showed a wide range of selectivity. In chronic glomerulo-
nephritis selectivity was low; but a high degree of selectivity 
was found in 16 ot 27 patients with amyloidosis. Selective pro-
teinuria was also found in two patients with thrombosis of a 
renal vein, in two of four patients with lupus nephritis, and in 
a patient with bronchial carcinoma. Arisz established a correla-
tion between selectivity and endogenous creatinine clearance in 
that selectivity was lower in patients with a low ECC. This 
correlation was particularly distinct in amyloidosis. In a group 
of over 400 patients in whom selectivity was studied, it was al-
ways found to be low when endogenous creatinine clearance was less 
than 20 ml/min. 
Brancaccio et ai. (1974) likewise found non-linearity of the sel-
ectivity measured from four protein molecules (albumin, trans-
ferrin, IgG and a2-macroglobulin) in focal glomerulosclerosis and 
amyloidosis. In a group of 37 patients, only 4 patients with min-
imal lesions showed a high degree of selectivity. Six patients 
with membranoproliferative glomerulonephritis all proved to show 
low selectivity. The remaining groups (focal glomerulosclerosis, 
focal proliferative glomerulonephritis, membranous nephropathy, 
renal amyloidosis and lupus nephritis) were found to comprise 
selective as well as non-selective proteinurias. Huttunen et al. 
(1975) examined 14 children with a congenital nephrotic syndrome 
and found selective proteinuria, like that associated with minimal 
lesions. 
The above survey of the literature shows that minimal lesions 
are always associated with selective proteinuria and a high sus-
ceptibility to glycocorticosteroids. Membranous glomerulonephritis 
was found associated with a high degree of selectivity by nearly 
all investigators, except the English group of Hardwicke and co-
workers. Renal amyloidosis, too, was found associated with selec-
tive proteinuria as long as glomerular renal function is not seri-
ously disturbed. Otherwise it can be generally stated that selec-
tivity decreases with increasing proliferative changes in the 
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histological picture. Of importance in our study is the question 
of the contribution which determination of the differential clear­
ance of proteins larger than IgG makes to our understanding of 
glomerular permeability, and experience with the urine concentra­
ting procedure required in this context in particular. Relevant 
data are conspicuously scanty. Blainey et al. (I960), for example, 
presented no data on the concentrating procedure used; no are such 
data found in publications by Hardwicke and Squire (1955) and 
Soothill (I960) , to which they refer for details on their methods. 
Later (Rowe and Soothill 1961; Soothill 1962) they continued to 
use the ultracentrifuge and ultrafiltration via Visking membrane. 
They reported that no losses were involved in concentrating and 
diluting urine, and found a coefficient of variation of 18% for 
albumin, 13% for IgG and 25% for a2-macroglobulin. Joachim and 
Cameron (1964), without specifying results, reported that dialysis 
of urine against distilled water via Visking membranes entailed 
no loss. Barcello and Polak (1966) , however, who used ultrafiltra­
tion via cellulose membranes with a pore diameter of less than 5 
my, often found no a2-macroglobulin, a2-lipoprotein and IgM in. 
the urine samples, and concluded that the literature pays little 
attention to the occurrence of artefacts. Poortmans et al. (1967) 
pointed out that reaggregation of IgG and IgA fragments to larger 
molecules can occur in the course of concentrating procedures. 
Arisz (1973), finally, argued that selectivity of proteinuria is 
best determined by measuring albumin, transferrin, IgG and α2-
macroglobulin. Registration of the quotient IgGialbumin or IgG: 
transferrin clearance supplies reasonably reliable information on 
selectivity. ci2-macroglobulin can be demonstrated only after con­
centration of urine, and consequently the results show considerable 
variations so that this protein seems more suitable for qualita­
tive than for quantitative and comparative studies. IgM is not 
homogeneous, and is not always present in the urine in measurable 
quantities, not even after very vigorous concentrating procedures. 
The same applies to 3-lipoprotein, and C3 complement is not stable 
in urine unless special precautions are taken, e.g. addition of 
EDTA. 
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Our study of the literature has demonstrated that the initial 
impression that the selectivity index could be indicative of the 
underlying disease and of the response to glycocortlcosteroid 
medication, has been gradually undermined in the course of the 
years. The only fact that really remains is that nephropathy due 
to so-called minimal lesions is usually, but by no means exclus-
ively, associated with selective proteinuria. Also of interest is 
the suggestion advanced by Arisz that high selectivity might be 
more indicative of an undisturbed GFR than of any particular un-
derlying disease. Finally, the question may be raised whether the 
use of natural proteins larger than IgG affords essentially new 
information. Be this as it may, the importance of the concentrat-
ing procedures required for these protein determinations merits 
critical evaluation. 
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Chapter VII 
DETERMINATION OF DIFFERENTIAL PROTEIN CLEARANCES 
METHODS AND PATIENTS 
Introduction. 
The selectivity of proteinuria was determined on relative clear-
ances of the natural protexns albumin, transferrin, IgG and a2-
macroglobulin. Use vías partly made ot the IgG:albumin clearance 
ratio according to Cameron and Blandford (1966) ; and in part the 
selectivity was studied over a larger range by relating the trans-
ferrin, IgG and a2-macroglobulin clearances to the albumin clear-
ance. The proteins in question were always determined by the tech-
nique of single radial immunodiffusion according to Mancini et al. 
(1965; . Special problems arise when the test material has to be 
diluted, as for serum determination, but especially when the 
material has to be concentrated, as for determination of a2-macro-
globulin in urine. A comparative study was made of a number of 
concentrating procedures. The various methodological aspects are 
discussed in this chapter. 
Single radial immunodiffusion. 
Radial immunodiffusion is based on the principle'that a solu-
tion which contains an antigen, when allowed to diffuse in a gel 
plate which contains an antibody, produces a precipitation circle 
whose surface area is proportionate to the antigen concentration. 
81 
Mancini et al. (1965) established experimentally, and Becker (1966) 
calculated theoretically that 
D 2 = K.CAg + d2, 
in which: 
D = diameter of the precipitation circle 
d = diameter of the cylindrical well to which the antigen 
solution is applicated 
CAg = concentration of the antigen 
К = diffusion constant. 
2 2 
Π — ri 
It follows that CAg = ç , in which d and К are constants 
determined, respectively, by the size of the depression (i.e. the 
volume of solution containing antigen) and the properties of the 
gel and the antibody concentration it contains. Factor К can be 
calculated for a given antibody-bearing gel plate from the sur­
face area of the precipitation circles of three solutions with 
known antigen concentrations. Once this is done, the antigen con­
centration in other solutions can be determined by interpolation 
from the measured diameters of the precipitation circles obtained 
with them. It is of importance that the end-point of the diffu­
sion process has been reached or exceeded at the time of reading. 
This is the case after 48 hours for albumin, transferrin and IgG, 
and after 72 hours for a2-macroglobulin. 
Materials used. 
Determinations of albumin, transferrin, IgG and a2-macroglobu-
lin (partly) were performed with commercial Partigen plates (Behr­
ing, Marburg, Germany): for albumin, M-Partigen-albumin OTBG-0 3 
(range 50-600 mg/100 ml); for transferrin, M-Partigen-transferrin 
OTBZ-03 (range 6-75 mg/100 ml); for IgG, Tri-Partigen-IgG OTDS-03 
(range 15-200 mg/100 ml) and LC-Partigen-IgG OTCR-03 (range 1-10.5 
mg/100 ml), and for a2-macroglobulin, M-Partigen-a2-macroglobulin 
OTBU-03 (range 25-350 mg/100 ml). 
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For determination of low a2-macroglobulin concentrations in urine, 
which remained below the range of M-Partigen-a2-macroglobulin 
OTBU-0 3 even after 50-fold concentration, home-made immunodiffusion 
plates were used. For this purpose 1% agarose (Hoechst Pharma) was 
dissolved in Tris barbital-sodium barbital (μ = 0.06; pH 8.θ) on 
a waterbath of 100 C. This solution was then cooled to 56 C, where­
upon rabbit anti-human a2-macroglobulin (code KH0 8, Central Lab­
oratory, Amsterdam Blood Transfusion Service) was added: 40 or 80 
yl to 12 ml agarose solution. After stirring, the gel was poured 
out on a level glass plate measuring 94 χ 84 mm. Once the agarose 
had congelated, 30 holes with a diameter of 2.6 mm were punched 
out with the aid of a template. The amount of test material to be 
applicated in these holes is 5 μΐ. The measurement range of these 
plates is 0.6-16.0 mg/100 ml at an antiserum concentration of 40 
μΐ, and 1.20-28.5 mg/100 ml at a concentration of 80 μΐ. The dif­
fusion time is 72 hours, as also for the M-Partigen OTBU plates. 
The free antiserum remaining after diffusion was washed out from 
the gel with physiological saline during 4 8 hours, and the plates 
were dried with a blower. Next, the precipitation rings were 
stained with a Coomassie Brilliant Blue solution: 5 g in 100 ml 
acetic acid concentrate, supplemented with 450 ml methanol and 
450 ml distilled water. The background colour developed in the 
gel was removed by washing with a 1% acetic acid solution during 
2 minutes. Characterization of the plate with standard dilutions, 
reading of the precipitation rings and interpolation of the values 
obtained, were as described for the Partigen plates. All immuno­
diffusion plates were stored at room temperature. 
Standard human serum ORDT-0 3 (Behring Werke) was used as standard 
serum. For characterization, three dilutions of this standard 
serum were made per plate, ranging from 1:5 to 1:70 for the M-
Partigen and Tri-Partigen plates, and from 1:100 to 1:1000 for the 
LC-Partigen plates. Serum samples were diluted 1:5 to 1:20, and 
urine samples were transferred undiluted. Concentration of urine 
was carried out only for determination of a2-macroglobulin. When­
ever the diameters of the precipitation circles obtained were less 
than 4 mm or more than 10 mm, a stronger or weaker dilution was 
used and the determination was repeated. 
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Diluting procedures. 
To prepare the dilution, we used Hamilton syringes type 701-N 
and 710-N (Hamilton, Bonaduz, Switzerland) and a Finn pipette 
continuously adjustable from 5 to 250 μΐ (Kemistien OY, Helsinki, 
Finland). For both types of syringe the variation in the amount 
sucked up was less than 3% in our laboratory. The amount sucked 
up was always 10 yl, which was transferred to a glass tube of 
45 χ 0.6 mm. Diluting to the required volume was done with physio­
logical saline. Standard sera and samples were stored under cover 
at -20 C, and always re-frozen after use. To serum and urine sam­
ples we always added a few granules of sodium azid in order to 
prevent bacterial growth. All determinations of diluted serum 
samples were made in duplicate. 
Concentrating procedures. 
A concentrating procedure is required for determination of a2-
macroglobulin in urine. In an effort to obtain information on re­
liability, a study was made of the results obtained by four meth­
ods: ultrafiltration with positive pressure, freeze-drying, rota­
tion evaporation, and dehydration with Sephadex G25. The test 
material used was pooled human serum which was diluted with physio­
logical saline or distilled water and then re-concentrated to the 
original volume. Deviations from this volume, if any, were cor­
rected in the calculations. For determination of the total pro­
tein concentration the biuret method was used, while radial immu­
nodiffusion was used for determination of albumin, transferrin, 
IgG and a2-macroglobulin. 
Ultrafiltration 
Ultrafiltration was performed with the use of Amicon cells of 
180 ml, suitable for the Diaflo membranes UM 05, PM 10 and ΧΜ 50, 
and an Amicon cell of 10 ml for Diaflo membrane XM 100 (Amicon 
Corporation, Lexington Mass., USA). The cells were placed on a 
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Cenco variable magnetic stirrer, and ultrafiltration was effected 
with the lowest possible positive pressure via compressed nitrogen, 
in accordance with the recommendations of the manufacturer. 
The molecular exclusion limits indicated for the abovementioned 
membranes by the manufacturer are: 
UM 05 > 500 molecular weight 
PM 10 > 10.000 molecular weight 
XM 50 > 50.000 molecular weight 
XM 300 > 300.000 molecular weight 
We diluted 1 ml pooled human serum to 50 ml with physiological 
saline, and then re-concentrated. 
Freeze-drying 
For this purpose 1 ml pooled human serum was diluted to 50 ml 
with distilled water; this was followed by 24 hours' dialysis 
against distilled water with a Visking membrane. The solution was 
then freeze-dried and the freeze-dried material was re-dissolved 
in 1 ml physiological saline. In the re-dissolving the problem 
arose that the volume of the freeze-dried material is many times 
that of the solvent. Loss of material is therefore highly probable. 
Rotation evaporation or film evaporation 
For this purpose 1 ml pooled human serum was diluted to 100 ml 
with a solution containing 0.18 g NaCl per litre, and this volume 
was then reduced to 1 ml in a rotation evaporator. 
Sephadex G25 coarse 
This method proved to be quite unsuitable for concentrating 
procedures up to 50 x. An amount of glutinous material remained 
behind, which could not be accurately collected. After a few at-
tempts, experiments with this technique were discontinued. 
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TABLE IX 
Diffevenaea in protein contents due to concentrating procedures 
Diaflo Membranes 
Pooled human serum UM 05 Difference PM 10 Difference 
mg/100 ml mg/100 ml % mg/100 ml % 
XM 50 Difference 
mg/100 ml % 
albumin 
transferrin 
IgG 
a2-macroglobulin 
3Θ30 
250 
1085 
326 
3900 
308 
308 
333 
+ 1.8 
+23.2 
+ 7.3 
+ 2.1 
3270 
250 
1070 
308 
- 14.6 
0 
- 1.4 
- 5.5 
3165 
237 
1055 
304 
- 17.4 
- 3.9 
- 2.7 
- 6.7 
albumin 
transferrin 
IgG 
a2-macroglobulln 
2740 
190 
750 
230 
1403 
135 
512 
156 
-48.8 
-28.9 
-31.7 
-32.1 
2437 
140 
563 
202 
- 11 
- 26.3 
- 24.9 
- 12.2 
2653 
175 
710 
192 
- 3.2 
- 7.8 
- 5.3 
- 16.5 
albumin 
transferrin 
IgG 
a2-macroglobulin 
4795 
306 
1110 
100 
4745 
287 
1110 
100 
- 1 
- 6.2 
0 
+ 10 
3820 
265 
988 
96 
20.3 
13.4 
11 
4 
albumin 
transferrin 
IgG 
a2-macroglobulin 
3925 
257 
915 
91 
4070 
215 
790 
87 
+ 3.7 
- 16.3 
- 13.6 
- 4.4 
3880 
230 
900 
96 
- 1.1 
- 10.5 
- 1.7 
+ 5.5 
albumin 
transferrin 
IgG 
а2-тасгод1оЬи1іп 
4340 
230 
1220 
19 
4550 
245 
1345 
16 
+ 4.8 
+ 6.5 
+ 10.3 
- 15.8 
3115 
183 
910 
19 
28.2 
20.4 
25.4 
0 
TABLE Χ 
Différences in •protein contents due to concentrating procedures 
by freezedrying and rotation evaporation 
Pooled human Freeze- Difference Rotation Difference 
serum drying evaporation 
mg/100 ml mg/100 ml % mg/100 ml % 
albumin 3830 2625 - 31.4 2401 - 37.3 
t r a n s f e r r i n 250 145 - 42 165 - 34 
IgG 1085 800 - 26.3 796 - 26.5 
o2-macroglobulin 326 
The r e s u l t s o b t a i n e d by c o n c e n t r a t i n g p r o c e d u r e s w i t h p o s i t i v e -
p r e s s u r e u l t r a f i l t r a t i o n v i a membrane UM 0 5 , PM 1 0 , ΧΜ 50 a n d 
t h o s e by f r e e z e - d r y i n g a n d r o t a t i o n e v a p o r a t i o n a r e p r e s e n t e d i n 
t a b l e s IX a n d X. T h e s e t a b l e s show t h a t f r e e z e - d r y i n g a n d r o t a ­
t i o n e v a p o r a t i o n a r e u n s u i t a b l e f o r q u a n t i t a t i v e d e t e r m i n a t i o n s . 
P o s i t i v e - p r e s s u r e u l t r a f i l t r a t i o n , t o o , c a n l e a d t o s i g n i f i c a n t 
p r o t e i n l o s s e s , w h i c h d i f f e r f o r d i f f e r e n t p r o t e i n s . The r e s u l t s 
o b t a i n e d w i t h t h e PM 10 a n d XM 50 m e m b r a n e s a r e b e t t e r t h a n t h o s e 
w i t h t h e UM 0 5 m e m b r a n e . 
The D i a f l o membrane XM 300 was s e p a r a t e l y t e s t e d w i t h a p o o l e d 
human s e r u m c o n t a i n i n g 312 mg a 2 - m a c r o g l o b u l i n p e r 100 m l . W i t h 
p h y s i o l o g i c a l s a l i n e , d i l u t i o n s w e r e p r e p a r e d a n d t h e n r e - c o n c e n ­
t r a t e d t o t h e o r i g i n a l v o l u m e . The d i l u t i o n s u s e d , t h e a 2 - m a c r o -
g l o b u l i n c o n t e n t a f t e r c o n c e n t r a t i o n a n d t h e l o s s p e r c e n t a g e s a r e 
p r e s e n t e d i n t a b l e X I . 
I n v i e w of t h e r e s u l t s p r e s e n t e d a b o v e , a l l n e c e s s a r y c o n c e n t r a t i n g 
p r o c e d u r e s f o r a 2 - m a c r o g l o b u l i n w e r e p e r f o r m e d w i t h p o s i t i v e - p r e s ­
s u r e u l t r a f i l t r a t i o n i n a 10 ml Amicon c e l l w i t h D i a f l o membrane 
XM 3 0 0 . T h i s t e c h n i q u e e n t a i l s l e s s l o s s of o 2 - m a c r o g l o b u l i n t h a n 
w i t h o t h e r m e m b r a n e s , a n d t h e h i g h e x c l u s i o n l i m i t of XM 300 i s 
a n a d v a n t a g e . P o l l a k e t a l . (1968) f o u n d t h a t p o s i t i v e - p r e s s u r e 
u l t r a f i l t r a t i o n y i e l d e d a l a r g e r p e r c e n t a g e of r e c o v e r y t h a n c o l -
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lodion ultrafiltration or rotation evaporation. They reported a 
recovery of 94.5 + 3.5% for Diaflo membrane UM 1. 
TABLE XI 
Loss of a.2-maoroglobul£n during a oonoentration 
procedure via Diaflo membrane XM 300 
Serum a2-macroglobulin Di lut ion 
leve l 312 mg/100 ml t o 
a2-macroglobulin in mg/100 ml 
a f t e r r e - c o n c e n t r a t i o n 
Loss 
1 ml 
1 ml 
1 ml 
0.5 ml 
10 ml 
40 ml 
50 ml 
20 ml 
290 
300 
27Θ 
312 
- 7.0% 
- 3 . 8 % 
-10.9% 
0 % 
C a l c u l a t i o n a n d a c c u r a c y o f d e t e r m i n a t i o n of d i f f e r e n t i a l p r o t e i n 
c l e a r a n c e s . 
I n p r i n c i p l e , t h e d i f f e r e n t i a l p r o t e i n c l e a r a n c e was c a l c u l a t e d 
a s q u o t i e n t o f t h e c l e a r a n c e s of t h e l a r g e s t a n d t h e s m a l l e s t m o l ­
e c u l e . F o r a l b u m i n a n d I g G , f o r e x a m p l e , t h i s c a l c u l a t i o n l e a d s 
t o t h e q u o t i e n t : 
U IgG U a l b V 
Ρ IgG Ρ a l b 
or, because V is the same in numerator and denominator, to the 
product 
P IgG 
Ρ alb 
U alb 
This product can be multiplied by 100 in order to express the 
clearance of the largest molecules as percentage of that of the 
smallest. In order to establish the reliability of the method se­
lected, the duplicate error was calculated as standard deviation 
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of the difference between duplicate determinations of serum sam­
ples according to the equation 
in which 
s = duplicate error 
Evi = difference between the two determinations of a protein 
from sample i 
η = number of duplicate pairs. 
In our material the duplicate error proved to be 8.5% in the de­
termination of serum albumin and 7% in that of serum IgG (n = 62). 
It may be assumed that the error in the urinary determination is 
probably less (or at worst equal), because diluting factors play 
no role in it. Over the four sample determinations required for 
calculation of the differential protein clearance, the coefficient 
of variation - in accordance with the law on propagation of errors 
- cannot be more than: 
V 2 χ 8.62 + 2 χ 7 2 = 15.7%. 
In our material the mean percentage IgG clearance in relation to 
albumin clearance (——?τ- χ 100) was 25%. Bearing in mind a va-
riation of 15.7% in the calculations, this means that a variation 
in the selectivity of 15.7% of this value, or 4%, must not be 
interpreted as a significant difference; consequently a difference 
of 4% in selectivity without and during indomethacin medication 
must not be regarded as an indomethacin effect. 
The determinations of cx2-macroglobulin in concentrated urine 
were made in duplicate, while the serum samples were transferred 
undiluted. The duplicate error of the determinations in urine 
was calculated to be 19.8% (n = 22). The overall error in the cal­
culation of the differential protein clearance from o2-macro-
globulin and albumin, accounting for an error of 10% due to the 
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concentrating procedure, should then be: 
V 2 χ 8.62 + 2 χ 19.82 + 102 = 32%. 
For his two-plate immunodiffusion method, Soothill (1962) calcu­
lated a coefficient of variation of 13-19%. Mancini et al. (1965) 
reported a coefficient of variation of 14% for their radial immuno­
diffusion method, and Cameron and Blandford (1966) reported 12%, 
measured over 102 determinations with this method. Arisz (1973) 
reported a coefficient of variation of 14% over 100 duplicate 
determinations for the method developed by Gell (1957) which, af­
ter modification, Soothill also used. 
Clinical procedure. 
Serum and urine samples from the patients in whom differential 
protein clearances were determined, as well as in some cases trans­
ferrin and a2-macroglobulin, were collected simultaneously during 
the period without indomethacin medication and on day 5 of the 
period of medication, 3 χ 50 mg indomethacin daily. Urine was 
collected daily in 24-hour portions, from 8.00 to 8.00 hrs. The 
creatinine excretion was used as a control on urine collection 
as well as for calculation of endogenous creatinine clearance. 
The proteinuria was also determined per 24 hours. Creatinine and 
protein in the patients' blood were determined on day 2 and day 5 
during indomethacin medication, and also on day 2 and day 5 during 
the period without indomethacin. The pathological diagnosis was 
established on the basis of a percutaneous kidney biopsy. 
Patients examined. 
Of 41 patients with a nephrotic syndrome hospitalized in our 
department, the selectivity of proteinuria was determined as meas­
ured from the percentage of IgG clearance in relation to albumin 
clearance. Table XII lists age, sex and diagnosis of these pa­
tients: 25 males and 16 females ranging in age from 18 to 72 years. 
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TABLE XII 
Some data on 41 patients with a nephrotic syndrome in 
whom differential protein clearanoes were carried out 
Patient Age Sex Diagnosis 
number 
Amyloidosis 
Membranoproliferative glomerulonephritis 
Membranoproliferative glomerulonephritis 
Focal segmental glomerulonephritis 
Rejection 
Focal segmental glomerulonephritis 
Rejection 
Amyloidosis 
Mesangial proliferative glomerulonephritis 
Membranoproliferative glomerulonephritis 
Membranoproliferative glomerulonephritis 
Membranous glomerulonephritis 
Segmental proliferative glomerulonephritis 
Focal segmental glomerulonephritis 
Intracapillary glomerulonephritis 
Focal glomerulonephritis 
Focal segmental glomerulonephritis 
Membranoproliferative glomerulonephritis 
Focal segmental glomerulonephritis 
Amyloidosis 
Focal segmental glomerulonephritis 
Rejection 
Focal segmental glomerulonephritis 
Focal segmental glomerulonephritis 
Membranous glomerulonephritis 
Membranous glomerulonephritis 
Proliferative glomerulonephritis 
Mesangial proliferative glomerulonephritis 
Minimal lesions 
Intracapillary glomerulonephritis 
Membranous glomerulonephritis 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
44 
24 
19 
32 
58 
26 
28 
60 
21 
27 
28 
40 
72 
28 
29 
45 
27 
25 
43 
70 
18 
30 
20 
40 
34 
52 
40 
35 
37 
24 
40 
f 
m 
f 
f 
m 
m 
m 
m 
f 
m 
f 
m 
m 
m 
f 
m 
m 
m 
m 
f 
f 
m 
f 
f 
m 
m 
f 
m 
m 
f 
m 
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Continuation: 
Patient Age Sex Diagnosis 
number 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
30 
44 
43 
34 
58 
42 
22 
26 
27 
56 
m 
m 
m 
f 
ш 
f 
ш 
f 
f 
m 
Membranous glomerulonephritis 
Minimal lesions 
Minimal lesions 
Membranous glomerulonephritis 
Membranous glomerulonephritis 
Membranoproliferative glomerulonephritis 
Membranoproliferative glomerulonephritis 
Focal segmental glomerulonephritis 
Membranous glomerulonephritis 
Membranous glomerulonephritis 
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Chapter Vili 
DIFFERENTIAL PROTEIN CLEARANCES IN PATIENTS WITH A NEPHROTIC 
SYNDROME AND THE EFFECT OF INDOMETHACIN ON THESE CLEARANCES 
Selectivity of proteinuria in relation to underlying disease and 
endogenous creatinine clearance. 
In 41 patients, efforts were made to establish a relation be-
tween selectivity of proteinuria as measured from albumin and IgG, 
and endogenous creatinine clearance. Figure 20 and table XIII show 
that there is a significant negative correlation between selecti-
vity of proteinuria and endogenous creatinine clearance when the 
total group is studied regardless of the underlying disease. 
When the 41 patients are classified by pathological diagnosis, 
the negative correlation between selectivity index and endogenous 
creatinine clearance proves to apply also to the nine patients 
with membranous glomerulonephritis and the nine with focal and 
segmental glomerulonephritis (table XIII). In the seven patiens 
with membranoproliferative glomerulonephritis and the ten with 
proliferative glomerulonephritis, no significant correlation be-
tween these two data proves to be demonstrable. It is also found 
that minimal lesions and renal amyloidosis are associated with 
selective proteinuria. These two groups of three patients each are 
too small, however, to calculate a reliable coefficient of corre-
lation. It can be stated, however, that the six patients with 
minimal lesions or renal amyloidosis all had an endogenous crea-
tinine clearance of 65 ml/min or more, as shown in fig. 20. 
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Fig. 20. Relation between selectivity and endogenous creatinine clearance in 
41 patients with various underlying diseases (r = -0.5Θ2; ρ < 0.001). 
• = minimal lesions 
+ = amyloidosis 
α = membranous glomerulonephritis 
л
 = focal segmental glomerulonephritis 
χ = membranoproliferative glomerulonephritis 
• = proliferative glomerulonephritis 
Membranous g l o m e r u l o n e p h r i t i s a l s o h a s a mean s e l e c t i v e p r o t e i n ­
u r i a . Only 3 p a t i e n t s i n t h i s g roup show a s e l e c t i v i t y index above 
20%: 26, 28 and 56%, r e s p e c t i v e l y , w i t h ' a n endogenous c r e a t i n i n e 
c l e a r a n c e of 90, 48 and 14 ml/min. This s e l e c t i v e p r o t e i n u r i a i n 
membranous g l o m e r u l o n e p h r i t i s was a l s o found by Joachim e t a l . 
(1964) and A r i s z ( 1 9 7 3 ) . T h i s f i n d i n g c o n t r a d i c t s r e p o r t s by t h e 
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TABLE XIII 
Correlation between selectivity index and endogenous creatinine clearance 
in 41 patients classified according to pathological diagnosis 
Pathological 
diagnosis 
Number of 
patients 
Selectivity index 
С IgG 
С alb 100 
range 
Correlation between 
selectivity index and 
ECC 
Г Ρ 
Minimal lesions 16 7-26 
Amyloidosis 4-14 
Membranous 
glomerulonephritis 20 6-56 - 0.880 < 0.01 
Focal segmental 
glomerulonephritis 30 16-53 - 0.760 < 0.05 
Membranoproliferative 
glomerulonephritis 22 10-34 0.245 NS 
Proliferative 
glomerulonephritis 10 24 9-38 0.419 NS 
Total 41 22 4-56 0.582 < 0.001 
British authors Squire, Blainey, Hardwicke and Soothill. Renal 
amyloidosis gives selective proteinuria in patients with still 
adequate glomerular filtration, as Arisz (1973) also mentioned. 
Selectivity decreases as the proliferative changes increases. 
A significant negative correlation between endogenous creatinine 
clearance and selectivity of proteinuria has been reported by 
other authors also (Braun and Merrill 1968; Arisz 1973). 
Effect of indomethacin on selectivity index (C IgG/C alb χ 100), 
proteinuria and endogenous creatinine clearance. 
The effect of indomethacin on proteinuria, endogenous creatin­
ine clearance and selectivity of proteinuria was studied in 33 
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TABLE XIV 
Effect of indomethaoin on endogenous creatinine clearance, 
proteinuria and selectivity index (γι—*τ· x 100) in 33 patients 
Patient ECC 
number Control Indomethaoin 
Proteinuria 
Control Indomethacin 
Selectivity index Sodium restriction (s) 
Control Indcmethacin and diuretics (d) 
1 
2 
3 
4 
5 
6 
7 
θ 
9 
10 
11 
12 
13 
14 
15 
16 
17 
85 
75 
107 
118 
34 
68 
44 
95 
95 
88 
85 
90 
49 
75 
133 
96 
88 
75 
64 
120 
34 
65 
40 
68 
53 
110 
86 
95 
90 
54 
24 
95 
94 
7.3 
7.8 
4.8 
6.1 
7.0 
8.2 
5.8 
11.1 
9.5 
3.2 
7.6 
9.2 
13.8 
12.1 
5.5 
6.3 
4.5 
5.5 
1.6 
2.1 
3.4 
2.9 
3.6 
3.2 
1.5 
3.4 
1.9 
5.7 
1.2 
5.4 
7.9 
1.9 
2.7 
4 
24 
23 
16 
27 
30 
29 
10 
21 
34 
34 
18 
38 
50 
22 
15 
16 
13 
27 
70 
22 
32 
6 
42 
24 
22 
32 
38 
17 
26 
32 
20 
7 
6 
s 
s+d 
s+d 
s 
Continuation 
Patient ECC Proteinuria Selectivity index Sodium restriction (s) 
number Control Indomethacin Control Indomethacin Control Indomethacin and diuretics (d) 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
110 
40 
73 
55 
89 
39 
54 
99 
81 
82 
90 
65 
107 
14 
48 
106 
78 
32 
63 
45 
83 
41 
43 
71 
73 
90 
88 
65 
134 
12.5 
48 
136 
10.2 
14.1 
5.2 
8.1 
9.6 
8.2 
5.7 
4.7 
6.4 
9.2 
10.6 
11.9 
4.9 
16.9 
8.6 
35.1 
2.9 
9.5 
2.4 
4.3 
4.0 
1.3 
4.7 
0.5 
0.9 
8.6 
6.8 
7.5 
4.1 
9.7 
5.3 
20.1 
15 
53 
14 
28 
9 
27 
31 
20 
10 
40 
22 
15 
13 
56 
28 
26 
10 
24 
10 
97 
36 
30 
21 
4 
24 
25 
8 
8 
12 
53 
34 
23 
s 
s 
s 
s 
s 
s 
s+d 
s+d 
s 
s 
s 
s 
s 
patients, of whom 23 were on a sodium-restricted diet while 10 had 
no sodium-restriction. A survey of the results is presented in 
table XIV, which shows that there are no data on proteinuria and 
endogenous creatinine clearance prior to indonethacin medication 
in patient no. 10. Patient no. 33 showed extreme proteinuria as a 
result of infusion of 250 ml plasma per day throughout the test 
period. 
In all patients the proteinuria decreased during indomethacin me-
dication; the mean proteinuria in 32 patients was 9.2 + 5.6 g/24 
hrs, while that during indomethacin medication was 4.6 + 3.8 
g/24 hrs. The mean decrease was therefore 4.6 + 2.9 g/24 hrs, or 
51 + 22%. 
The 22 patients on a sodium-restricted diet showed a mean protein-
uria of 10.3 + 6.4 g/24 hrs, which during indomethacin medication 
decreased to 5.3 + 4.3 g/24 hrs. The mean decrease was therefore 
4.9 + 3.1 g/24 hrs, or 49 + 24%. 
As figure 21 shows, the mean proteinuria in the 10 patients on an 
unrestricted sodium intake was less: 6.9 + 2.2 g/24 hrs. During 
indomethacin medication this decreased to 3.0 + 1.6 g/24 hrs, a 
mean decrease of 3.8 + 2.4 g/24 hrs, or 53 + 23%. The two groups 
of patients were remarkably similar in the decrease in proteinuria. 
Both the mean decrease in proteinuria and the mean percentual de-
crease in the two groups showed no significant difference (Stud-
ent's t-test). 
In only 20 of the 32 patients the endogenous creatinine clearance 
decreased; in 5 patients it remained constant, and 8 showed an 
increase. Separate consideration of the sodium-restricted and un-
restricted group revealed no difference in effect on endogenous 
creatinine clearance between the two groups (figure 22). The clear-
ance decreased in 14 of the 22 sodium-restricted patients, remained 
constant in 2, and increased in 6 patients. It decreased in 5 of 
the 10 unrestricted patients, remained constant in 3, and in-
creased in 2 patients. The mean percentual decrease in clearance 
was 11 + 18% for the entire group of 32 patients, 10 + 20% for 
the sodium-restricted group, and 13 + 18% for the unrestricted 
group. The two groups proved not to differ significantly either 
in mean changes of endogenous creatinine clearance or in mean 
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percentual changes (Student's t-test). 
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Fig . 21 . Effect of indomethacin on p r o t e i n u r i a in 22 p a t i e n t s on a sodium-
r e s t r i c t e d and 10 on an u n r e s t r i c t e d d i e t . 
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Fig. 22. Effect of indomethacln on endogenous creatinine clearance in 22 pa­
tients on a sodium-restricted and 10 on an unrestricted diet. 
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Fig. 23. Absence of a relation between the effect of indanethacin on endogenous 
creatinine clearance and that on proteinuria. 
When the decrease in proteinuria is plotted against the effect on 
endogenous creatinine clearance as shown in figure 23, no direct 
relation between the two effects is demonstrable. If it were, then 
all arrows indicating the decrease in proteinuria should also point 
to the intersection of abscissa and ordinate. 
Figure 24 shows the effect of indomethacin on selectivity in the 
33 patients, this time divided into a group of 16 patients with 
selective proteinuria and one of 17 patients with non-selective 
proteinuria during the control period. Overall, selectivity in-
creased in 19 of the 33 patients and decreased in 14 during indo-
methacin medication. Selectivity increased in 10 and decreased in 
6 of the 16 patients with selective proteinuria; it increased in 
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Fig. 24. Effect of indomethacin on select ivi ty . Left: 16 patients with selec-
tive proteinuria. Right: 17 patients with non-selective proteinuria. 
10 and d e c r e a s e d in 7 of t h e 17 p a t i e n t s w i th n o n - s e l e c t i v e p r o -
t e i n u r i a . The group of s e l e c t i v e p r o t e i n u r i a , t h e r e f o r e , d i d n o t 
d i f f e r from t h a t of n o n - s e l e c t i v e p r o t e i n u r i a i n indomethac in 
e f f e c t . 
As c a l c u l a t e d in c h a p t e r V I I , only changes in s e l e c t i v i t y index 
by 4% or more exceed t h e e r r o r of measurement i n t he d e t e r m i n a -
t i o n . Bear ing t h i s i n mind, we f i nd t h a t i n c r e a s e d s e l e c t i v i t y 
occu r red in only 6 p a t i e n t s of t he s e l e c t i v e , and 7 p a t i e n t s of 
t he n o n - s e l e c t i v e g r o u p . O v e r a l l , 13 of t he 33 p a t i e n t s showed i n -
c r e a s e d s e l e c t i v i t y , and 7 showed a d e c r e a s e t o such an e x t e n t as 
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to exceed the range of the determination. In the remaining 13 pa-
tients there was no distinct difference in selectivity. 
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Fig. 25. Effect of indomethacin on selectivity related to that on endogenous 
creatinine clearance. 
A study of the effect of indomethacin on selectivity in relation 
to the effect on endogenous creatinine clearance, as shown in fig-
ure 25, reveals no distinct relation between these effects; spec-
ifically, a possible effect on selectivity cannot be related to 
the level of endogenous creatinine clearance in the untreated pa-
tient. 
Figure 26 shows that selectivity increased in 16 of the 23 patients 
with a sodium-restricted diet, and only in 3 of the 10 with an 
unrestricted diet. Taking into account the error of measurement, 
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we find that selectivity increased in 6 sodium-restricted patients 
and decreased in 5. In the unrestricted group, selectivity in-
creased in 3 and decreased in 2 patients. Consequently, no consis-
tent change in selectivity of proteinuria occurred during indo-
methacin medication, and in this respect sodium-restricted patients 
did not differ from those on an unrestricted diet. 
1 1 1 1 
control tndomethacin control indomethacin 
sodium restricted sodium containing 
diet diet 
Fig. 26. Effect of indomethacin on select ivi ty in 23 patients on a sodium-
restr ic ted and 10 on an unrestricted d ie t . 
Next we s t u d i e d t h e q u e s t i o n whether t h e amount of oedema and t h e 
serum albumin l e v e l might e x e r t an i n f l u e n c e on changes i n s e l e c -
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TABLE XV 
Serwn albumin level, amount of oedema, differential protein olearanae and en-
dogenous Creatinine olearance in 22 patiente on a sodiwrt-restrioted diet, 
before and during indome thaoin médication 
Patient Serum albumin Amount of - — 2 _ . Endogenous creatinine 
number g/1 oedema clearance 
1 
5 
6 
7 
θ 
10 
12 
14 
15 
16 
1Θ 
19 
20 
22 
23 
24 
25 
26 
27 
28 
29 
31 
33 
19.0 
23.7 
34.9 
29.9 
13.9 
18.5 
8.8 
14.6 
31.0 
19.3 
15.6 
17.1 
29.3 
15.0 
10.5 
31.1 
32.1 
29.3 
20.0 
18.1 
23.6 
19.9 
20.6 
27.0 
36.9 
31.3 
19.1 
25.8 
22.9 
14.2 
18.8 
32.0 
29.1 
16.5 
18.4 
31.9 
15.7 
13.1 
37.4 
34.3 
29.6 
16.7 
16.0 
26.8 
21.4 
+ 
+ 
-
+ 
+ 
-
++ 
+++ 
+ 
-
+ 
++ 
++ 
+ 
+ 
+++ 
-
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-
+ 
+ 
-
++ 
+++ 
+ 
-
+ 
++ 
++ 
+ 
+ 
+++ 
-
+ 
+ 
+ 
+ 
+ 
+ 
0.04 
0.27 
0.25 
0.29 
0.10 
0.34 
0.18 
0.50 
0.22 
0.15 
0.15 
0.53 
0.14 
0.09 
0.27 
0.31 
0.20 
0.10 
0.40 
0.22 
0.15 
0.56 
0.26 
0.13 
0.32 
0.06 
0.42 
0.24 
0.32 
0.17 
0.32 
0.20 
0.07 
0.10 
0.24 
0.10 
0.36 
Ό. 30 
0.21 
0.04 
0.24 
0.25 
0.08 
0.08 
0.53 
0.23 
85 
34 
68 
44 
95 
85 
49 
75 
133 
П О 
40 
73 
89 
39 
56 
99 
81 
82 
90 
65 
14 
106 
88 
34 
65 
40 
68 
110 
95 
54 
24 
95 
78 
32 
63 
83 
41 
45 
71 
73 
90 
88 
65 
12.5 
136 
Left columns: before indomethacin 
Right columns: during indomethacin 
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tivity. For this patients we studied sodium-restricted patients. 
Those on an unrestricted diet showed no oedema and had serum al-
bumin levels of 28.9-40.2 g/1. Table XV lists the data on serum 
albumin levels, effect on selectivity and endogenous creatinine 
clearance and semi-quantitative evaluations of the amount of oe-
dema. The amount of oedema was scored as follows: 
- = no oedema 
+ = trace of circummalleolar or pretibial oedema 
++ = pitting oedema of the lower legs 
+++ = oedema elsewhere also (> 5 kg). 
This table shows that the degree of oedema, or the serum albumin 
level, does not correlate with changes in selectivity during in-
domethacin medication. Selectivity did increase in patients 14 and 
24, with +++ oedema and serum albumin levels of 8.8 and 10.5 g/1, 
respectively, and also in two of the three patients with ++ oede-
ma (patients 19 and 20), but the same was observed in patients 6, 
16 and 25, who showed not a trace of oedema and whose serum albu-
min levels did not suggest a significant degree of hypovolaemia. 
Patient 10, too, showed no oedema and virtually no change in 
selectivity. 
Effect of indomethacin on selectivity measured from albumin, trans-
ferrin, IgG and a2-macroglobulin. 
In 17 patients, transferrin and a2-macroglobulin were deter-
mined as well as albumin and IgG in order to establish whether 
determination of the former two proteins might influence the data 
on selectivity as so far presented. Albumin, transferrin, IgG and 
o2-macroglobulin have increasing molecular weights, 67.000, 88.000, 
150.000 and 820.000, respectively. When the relative clearance of 
the last three proteins in relation to albumin is plotted on a 
logarithmic scale against the logarithm of molecular weight, a 
regression line can be calculated from the points obtained. Table 
XVI lists the results of the relative clearances of these proteins, 
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TABLE XVI 
Relative clearances of transferrin, IgG and a2-macroglobulin expressed as percentage 
of albumin clearance, before and during indomethacin medication 
P a t i e n t T r a n s f e r r i n IgG a2-macroglobulin -К r ρ Θ 
number 
1 
2 
5 
6 
7 
12 
14 
15 
20 
21 
23 
25 
26 
27 
28 
29 
32 
80 
147 
129 
119 
138 
53 
167 
81 
82 
37 
117 
125 
100 
98 
96 
79 
97 
88 
96 
110 
101 
140 
85 
1.14 
80 
91 
109 
103 
200 
96 
100 
40 
22 
103 
4 
25 
27 
25 
29 
18 
50 
22 
14 
28 
27 
20 
10 
40 
22 
15 
28 
13 
27 
32 
6 
42 
17 
32 
20 
10 
97 
30 
4 
24 
25 
8 
8 
34 
0.1 
3 
0.1 
2 
0.1 
2 
0.5 
4 
negative 
negative 
3 2 
negative 
0.9 
0.2 
3 
1.1 
0.8 
1 
2.6 
0.1 
1.5 
0.2 
0.2 
2 
1.3 
0.6 
2 
0.3 
0.1 
1.2 
2.82 
1.52 
2.94 
1.66 
1.56 
1.92 
2.44 
1.49 
1.91 
1.99 
1.93 
1.51 
2.85 
1.75 
2.86 
1.62 
2.24 
1.30 
1.60 
2.57 
2.65 
1.64 
1.88 
2.13 
1.63 
2.26 
2.62 
1.86 
-0.981 
-0.971 
-0.989 
-0.989 
-0.976 
-0.990 
-0.988 
-0.984 
-0.986 
-0.974 
-0.991 
-0.987 
-0.997 
-0.996 
-0.997 
-0.995 
-0.991 
-0.835 
-0.992 
-0.992 
-0.957 
-0.994 
-0.886 
-0.996 
-0.992 
-0.993 
-0.994 
-0.994 
0.05 
0.05 
0.01 
0.05 
0.05 
0.01 
0.05 
0.05 
0.05 
0.05 
0.01 
0.05 
0.01 
0.01 
0.01 
0.01 
0.01 
NS 
0.01 
0.01 
0.05 
0.01 
NS 
0.01 
0.01 
0.01 
0.01 
0.01 
70.5 
57 
71 
59 
57 
62 
68 
56 
62 
63 
63 
56 
71 
60 
70 
58 
66 
52 
59 
69 
69 
59 
62 
65 
58 
66 
69 
62 
о Left columns: before indomethacin; right columns: during indomethacin 
expressed as percentage of albumin clearance, without and during 
indoraethacin medication. It also mentions the angle of slope of 
the regression line calculated, the correlation coefficient and 
its significance. 
θ = angle of slope of the regression line, calculated through 
the four points obtained by plotting the relative protein 
clearances against the molecular weights on a double logar­
ithmic scale, on the y-axis and x-axis, respectively. 
К = - tangent 0 
r = correlation coefficient 
ρ = significance of correlation coefficient. 
The table reveals a good, significant correlation between the 
logarithms of the relative protein clearances and those of their 
molecular weights, except in patients 6 and 25 during indometha-
cin medication. The angle of slope (Θ) does not significantly in­
crease during indomethacin medication, for the angle increases in 
9 patients, decreases in 4, and remains constant in one (patient 
25). The mean Θ is 62.5 + 5.6° without, and 63.2 + 5.5° during 
indomethacin medication. 
Using the data from table XVI, the relative clearances of trans­
ferrin, IgG and a2-macroglobulin are again presented in figure 27 
as percentage of albumin clearance, plotted on a double logarith­
mic scale. This figure shows that determination of o2-macroglob-
ulin makes no essential contribution to the angle of slope obtain­
ed before and during indomethacin medication. 
When a2-macroglobulin is omitted in the calculation of Θ, the mean 
angle becomes 62.5 + 8.2 without, and 60.7 + 18.0° during indo­
methacin medication. Again, no significant difference is demon­
strable between the mean Θ before and during indomethacin medi­
cation. Classification into sodium-restricted and unrestricted 
patients does not influence these results. Only patients 2, 21 
and 32 in table XVI were on an unrestricted diet. In 14 of the 17 
patients in whom a2-macroglobulin was determined, this was demon­
strable (as shown in table XVI). Comparing the relative clearance 
of a2-macroglobulin in relation to albumin without and during 
indomethacin medication, we find that selectivity increases in 7 
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patients, remains constant in 3 and decreases in 4, as shown in 
figure 28. Measured from albumin and a2-macroglobulin, too, no 
consistent effect on selectivity during indomethacin medication 
is demonstrable. 
clearance (% albumin clearance) 
control 
100 
6788 150 6788 150 820 (x10~3) 
molecular weight 
Fig. 27. Relative clearances of trarsferrin, IgG and a2-macroglobulin ex-
pressed as percentage of albumin clearance, without and during indomethacin 
medication. 
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Fig. 28. Differential protein clearance measured from albumin and a2-macro-
globulin in 14 patients, without and during indomethacin medication. 
Discussion. 
This study shows that, in patients with a nephrotic syndrome, 
indomethacin reduces the proteinuria, to a quantitatively similar 
extent with and without sodium-restriction. That this effect should 
be accompanied by an increase in selectivity, as might perhaps be 
expected from the results of the study with fractional PVP clear-
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anees, was not confirmed. In our material there was no consistent 
effect on selectivity of proteinuria, and this contradicts the 
findings reported by Arisz et al. (1976) . 
The effect of indomethacin on proteinuria has no direct relation 
to the effect, if any, on endogenous creatinine clearance; nor 
does an effect on selectivity, if any, show any relation to an 
effect on endogenous creatinine clearance, if any. Sodium res-
triction or non-restriction caused no difference in the effect on 
proteinuria or in that on endogenous creatinine clearance. A sig-
nificant negative correlation was found between selectivity of 
proteinuria and endogenous creatinine clearance in untreated pa-
tients, but the effect of indomethacin on selective did not differ 
from that on non-selective proteinuria. 
Our findings show that the selectivity of proteinuria is related 
much more to endogenous creatinine clearance than to the patho-
logical diagnosis. This makes it understandable that minimal le-
sions, membranous glomerulonephritis and renal amyloidosis show 
selective proteinuria as long as glomerular filtration is only 
slightly disturbed. Additional determination of the proteins trans-
ferrin and a2-macroglobulin gives no more exact information on the 
selectivity of proteinuria. 
Ill 
Chapter IX 
OVERALL DISCUSSION OF RESULTS AND SUMMARY 
To introduce the discussion of the results of this study, we 
present a summary of the principal data related to the problem 
statement in chapter I. 
Indomethacin medication, 3 χ 50 mg per day orally during 5 days, 
had a limited effect on fractional PVP clearance. It reduced the 
permeability to PVP molecules with a molecular radius larger than 
40 A. Of course this effect was demonstrable only in patients who, 
when untreated, showed an increased permeability to these molec­
ules. In our study the phenomenon was observed in 13 out of 16 
patients with a reduced clearance of PVP molecules with a radius 
smaller than 40 8, and in 4 out of 5 patients with a normal clear­
ance of PVP molecules of this size. 
Indomethacin medication, 3 χ 50 mg daily during 5 days, had no 
significant and consistent effect on the selectivity index meas­
ured from the relative clearances of the natural proteins IgG and 
albumin. Nor was an effect found on the selectivity for natural 
proteins over a wider range of molecular size, measured from al­
bumin, transferrin, IgG and a2-macroglobulin. Division of the pa­
tients into an unrestricted and a sodium-restricted group and into 
a group with and one without oedema did not separate those who 
did from those who did not respond to indomethacin by an increase 
in selectivity of proteinuria. 
All the patients examined responded to indomethacin medication 
by a significant decrease in proteinuria. The degree of decrease 
could not be correlated to the effects on fractional PVP clear-
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ance or on selectivity index. Nor was a relation established be-
tween the decrease in endogenous creatinine clearance sometimes 
seen in response to indomethacin, and the effect of the drug on 
proteinuria. Patients on a sodium-restricted diet did not differ 
from those on an unrestricted diet in effects on proteinuria and 
endogenous creatinine clearance. 
At least for the largest molecules studied, therefore, there was 
a descrepancy between the results of the PVP study and those of 
the study with natural proteins. The existence of such a discrep-
ancy has been previously mentioned in the literature. Cassée et al. 
(1968) were the first to report a poor correlation between the 
two methods. They doubted the correctness of the permeability 
slope for PVP molecules, but thought that dissociation of large 
or polymerization of smaller protein molecules in the urine might 
also afford an explanation. 
Arturson et al. (1971) maintained that differences in permeabili-
ty slopes for dextrans and natural proteins in spite of equal 
Einstein-Stokes radii, were probably based on differences in elec-
trical charge. Hardwicke (1972) believed that the discrepancy in 
permeability between proteins and PVP was based on differences in 
physical properties; he demonstrated that PVP fractions also pass 
through a cuprophane membrane more easily than protein molecules 
of equivalent radius. Pétrie et al. (1968), who found a good cor-
relation between dextran and protein molecule clearances in patients 
with minimal lesions and membranous glomerulonephritis, but not 
in those with proliferative glomerulonephritis, assumed that only 
diseased glomeruli leak proteins so that, in the case of a non-
diffuse pathology, this protein loss should be confined to a few 
glomeruli; this would produce a discrepancy: an increased permea-
bility to proteins with an unchanged permeability to dextrans. 
Arisz (19 73) suggested that the discrepancy between the clearance 
of protein and that of PVP molecules of equivalent size had to 
be based on tubular reabsorption of proteins, on the absence of 
an electrical charge in PVP molecules, and on a different molec-
ular shape. Renkin et al. (1973, 1974) concluded that the differ-
ences in the clearance of substances of the same molecular weight 
should be based on differences in shape and charge. The more 
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flexible polymer chains, they believed, should pass more easily; 
and the electrical charge should also be a factor of importance 
in this respect. Recent research has revealed that, in Wistar rats 
with nephrotoxic glomerulonephritis, the permeability to dextran 
sulphate molecules with a negative charge is increased, while 
that to neutral dextran molecules of equivalent radius is decreas-
ed in relation to the permeability in normal rats (Bennet et al. 
1976; Chang et al. 1975, 1976). The lastmentioned investigations 
were carried out with dextran fractions of 18-42 8, and conse-
quently the effects on permeability to molecules larger than 40 A 
were not as such studied. On the basis of these findings, and in 
view of the reliability of fractional PVP clearances based on de-
terminations over a relatively wide range of molecular radii, we 
believe that the effect of indomethacin on PVP molecules with a 
radius of more than 40 A is beyond doubt, although no such effect 
is observed on the large natural proteins IgG and a2-macroglobulin. 
Concerning the effect of indomethacin on GFR, our findings dif-
fer from those of Arisz et al. (1976). The latter found a mean 
decrease in GFR of 35%, versus a mean decrease of 11% in our study. 
Moreover, Arisz et al. invariably found a decrease in GFR, where-
as in our study this was by no means a constant finding. In this 
context it is to be noted that the Groningen investigators meas-
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ured the GFR with the aid of I-labelled sodium iothalamate, 
whereas in our study the less accurate endogenous creatinine clear-
ance was utilized. Yet we have no doubt, in view of this study 
and previous experience (Wijdeveld 1971), that the antiproteinuric 
effect of indomethacin can develop without a decrease in, at least, 
endogenous creatinine clearance and that, moreover, it can devel-
op so quickly that this phenomenon cannot be explained as a con-
sequence of compensation of a decrease in GFR in response to indo-
methacin, due to an increase resulting from improved circulation 
due to the increased plasma albumin concentration. Our study also 
differs from that described by Arisz et al. with regard to the 
effect of indomethacin on the selectivity of proteinuria. The 
Groningen authors always found an increased selectivity of pro-
teinuria, which contradicts our findings. These differences do not 
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seem to be due to differences in methods used. It may be assumed 
that the days on which the investigations were made in the two 
studies, are comparable. The degree of hypalbuminaemia likewise 
seems comparable, and the same seems to apply to the degree of 
sodium restriction. Finally, the methods used by the Groningen 
authors are comparable with those we employed. 
Reviewing all the available data, we must conclude that this 
study does not prompt a confirmative answer to the principal ques-
tion considered: can the effect of indomethacin on proteinuria 
in patients with a nephrotic syndrome be explained by a decrease 
in glomerular permeability in response to the medication? In ac-
tual fact, an effect of indomethacin on permeability over the en-
tire range of the PVP molecules studied has not been observed 
either in patients with normal or in those with decreased permea-
bility to macromolecules. The effect of indomethacin on permeabi-
lity to PVP molecules larger than 40 8 will have to be explained 
in a different way. This effect prompts associations with a recent 
study by Hulme and Pessina (1975), who studied the effect of 
angiotensin infusions on fractional PVP clearances in rats and 
found that angiotensin caused increased relative clearance of 
molecules larger than 40 8; at the same time the proteinuria in-
creased. The effect of indomethacin could be the opposite of this 
effect. One might assume that the hyperangiotensinaemia which can 
be expected in patients with a nephrotic syndrome, causes the pro-
teinuria to increase, and also permeability to PVP molecules larger 
than 40 A. Should indomethacin reduce the hyperangiotensinaemia, 
and studies by Arisz et al. (1976) and Donker et al. (1976) justi-
fy this assumption because they observed a decrease in plasma 
renin activity in response to indomethacin, then the agent might 
remove part of the proteinuria via this route, and could also re-
duce the increased clearance of PVP molecules larger than 40 8. 
However, this theory does not seem to explain all the findings. 
Indomethacin also reduces proteinuria in patients without increas-
ed clearance of macromolecules, as well as in those whose hypalbu-
minaemia is so slight that markedly increased angiotensin activi-
ty is improbable. Moreover, the side effects of indomethacin - the 
decreased GFR sometimes observed, the decreased renal blood flow 
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which Arisz et al. sometimes found, the effects on sodium excre-
tion and the excretion of other dissolved constituents (Wijdeveld 
1971) and the effects on natriuresis in response to furosemide 
(Tiggeler et al. 1977) - are suggestive of anything but decreased 
angiotensin activity. Another possible explanation of the effect 
of indomethacin on increased clearance of large macromolecules 
could be that this phenomenon indicates serious lesions of a num-
ber of glomeruli, and that the contribution of these glomeruli 
to the total filtration process is reduced in response to indo-
methacin. 
The question how the effect of indomethacin on proteinuria 
should be explained now that an effect on glomerular permeability 
seems to be excluded, is not within the scope of this study. How-
ever, we are tempted to present a few speculative remarks in this 
context, not so much in an effort to explain as in an effort to 
outline further avenues of research. 
Apart from glomerular permeability in the strict sense of the 
word, there are two other factors which might influence the pas-
sage of large molecules through the glomerular membrane: inter-
ference of the electrical charge of such molecules with the nega-
tive charge of the polyanion, and the haemodynamic conditions in 
the glomerular capillaries. 
Recent studies made by Brenner's group in Munich Wistar rats 
with nephrotoxic nephritis have on the one hand confirmed that 
proteinuria in glomerulonephritis can be associated with decreased 
glomerular permeability to neutral dextran fractions (Chang et al. 
19 76), as was demonstrated for PVP also in our study and in pre-
vious investigations by Hulme et al. (196 8) and Robson et al. 
(1974); on the other hand, however, they have shown (Bennett et al. 
1976) markedly increased permeability to negatively charged dex-
tran sulphate fractions, to which the normal glomerular membrane 
has a permeability which compares with that to albumin (Chang et 
al. 1975) . This study has led to the hypothesis that the protein-
uria in glomerulonephritis is based at least in part on specifical-
ly increased permeability to negatively charged proteins as a 
result of destruction of the fixed negative charge in the sialo-
protein of the so-called glomerular polyanion. Should indomethacin 
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interfere with this system, e.g. by partially restoring the nega-
tive charge, then this might offer an explanation of the anti-
proteinuric effect. In this context a study of the effect of in-
domethacin on the permeability characteristics for dextran sul-
phate might be of importance. It should be mentioned, however, 
that - at least in rats with a nephrotic syndrome on the basis of 
experimental extramembranous glomerulonephritis - indomethacin 
can produce an antiproteinuric effect only if the rats are given 
a sodium-restricted diet (Gribnau 1975). 
The lastmentioned finding, together with the very rapid effects 
of indomethacin on the excretion of sodium and other solutes in 
the urine (Wijdeveld 1971), its variable effects on glomerular 
filtration, its variable effects on renal blood flow (Arisz et al. 
1976; Donker et al. 1976), and the suppression of the effect of 
strong diuretics (Tiggeler et al. 1977), perhaps can be seen as 
suggestive of an influence of indomethacin on another factor 
among the determinants of glomerular permeability: the glomerular 
haemodynamic conditions. Any explanation in this direction would 
probably best start from the more recent views on the mechanism 
of action of indomethacin as inhibitor of prostaglandin synthesis 
(Vane 1971; Ferreira and Vane 1974). The renal prostaglandins are 
known to effect redistribution of the intrarenal blood flow to the 
cortical nephrons (Zins 1975). Furosemide is known to have a simi-
lar effect (Birth et al. 1967). It seems possible that this effect 
is mediated by increased renal prostaglandin activity, because 
furosemide can block the degradation of prostaglandins by inhi-
bition of prostaglandin dehydrogenase activity in the cortex 
(Bailie et al. 1975). Consequently it does not seem unreasonable 
to assume that a prostaglandin inhibitor such as indomethacin 
might produce the opposite effect. The consequence of this redis-
tribution would be that part of the nephron population receives 
a higher, and another part a lower glomerular blood flow. Brenner's 
group has theoretically defined the effects of variations in 
glomerular perfusion on glomerular permeability (Deen et al. 1973; 
Chang et al. 1975), and tested it in single nephron studies. Spe-
cifically, they found that the relative clearance of macromolecules 
decreases with increasing blood flow, and increases with decreasing 
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flow. An explanation is sought in a relation between the point 
along the longitudinal axis of the glomerular capillary at which 
filtration equilibrium, equality of hydrostatic and oncotic pres-
sure, is attained, and the plasma flow rate in the capillary. 
With an increasing flow rate, this point shifts in the direction 
of the efferent arterioles, so that throughout the capillary a 
lower concentration gradient develops of substances transported 
by diffusion. The opposite would apply when the glomerular blood 
flow rate decreases. 
Any explanation of the effects of indomethacin along these lines 
should account also for the influence of an existing glomerulo-
nephritis, an existing nephrotic syndrome, and inhibition of pro-
staglandin activity on glomerular haemodynamics. Studies by the 
same group (Maddox et al. 1975; Chang et al. 1976) have shown that 
experimental nephrotoxic nephritis produces enormous changes in 
glomerular haemodynamics. Specifically, the hydrostatic pressure 
gradient between capillary and capsular space proves to increase, 
and filtration equilibrium is found to develop only late or not 
at all. The presence of hypalbuminaemia, too, in principle shifts 
the point at which filtration equilibrium is attained in the dir-
ection of the efferent arterioles, because the oncotic pressure is 
lower. Finally, it is possible that an intact prostaglandin sys-
tem is required for proper auto-regulation of the glomerular blood 
flow, with an increase in resistance in the afferent and a decrease 
in the efferent arterioles with increasing blood flow (Deen et al. 
1974). 
In view of all these factors, speculations on a possible influ-
ence of indomethacin on glomerular haemodynamics are unjustifiable 
without quatitative data, partly also because the expected effects 
on permeability to PVP were not really found in our study. It would 
be of great importance to study the effects of indomethacin on 
renal and glomerular haemodynamics in isolated kidneys or single 
nephrons. 
The problem statement of this study may be answered in conclu-
sion as follows: 
1. Indomethacin has no effect on glomerular permeability measured 
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from fractional clearances of polydisperse polyvinylpyrrolidon. 
It decreases permeability to PVP molecules larger than 40 Я in 
patients who showed an increased permeability to these molec­
ules when untreated. This effect may be the consequence of 
suppression of raised angiotensin activity in patients with the 
nephrotic syndrome. 
Indomethacin has no effect on glomerular permeability measured 
from differential clearances of natural proteins as large as 
a2-macroglobulin. 
To explain the effect of indomethacin on proteinuria, GFR, 
renal plasma flow and on the excretion of dissolved substances 
more research has to be recommended, and pointed at possible 
influence of the drug on the electrical charge of the glomeru­
lar polyanion and on glomerular haemodynamic factors in glom­
erulonephritis . 
119 
120 
LIST OF SYMBOLS AND ABBREVIATIONS 
A = effective area of the pore 
Ao = total cross-sectional area of the pore 
a = molecular radius 
^P = length-averaged value of the glomerular transcapillary 
hydraulic pressure difference 
Tn = length-averaged value of the glomerular transcapillary 
oncotic pressure difference 
ε = hydrostatic intracapillary pressure gradient 
FF = filtration fraction = GFR/RPF 
GFP = integrated mean effective filtration pressure 
GFR = glomerular filtration rate 
K
a v
 = penetrable gelvolume fraction = elution constant = 
Ve-Vo 
Vt-Vo 
Kf = ultrafiltration coefficient 
ρ = protein concentration of arterial plasma 
Pc = mean hydrostatic pressure in Bowman's space 
Pgc = mean glomerular capillary hydrostatic pressure 
ΠΑ = initial glomerular capillary colloid osmotic pressure 
Пдс = mean glomerular capillary colloid osmotic pressure 
Од = initial (afferent) glomerular plasma flow rate 
RPF = renal plasma flow 
Rs = Einstein-Stokes radius 
r = pore radius 
SNFF = single nephron filtration fraction 
SNGFR = single nephron glomerular filtration rate 
Ve = elution volume in gelchromatography 
Vi = solvent volume internal to the gel phase 
Vo = void volume of gelcolumn 
Vt = total volume of gelcolumn 
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STELLINGEN 
1 
De selectiviteit van een Proteinurie verschaft geen informatie 
omtrent de aard van de nieraandoening die de Proteinurie veroor-
zaakt, maar zegt hoogstens iets over de mai_e van glomerulaire 
nierfunktiestoornis. 
- dit proefschrift 
2 
Het verminderen van de uitscheiding van fibrinedegeneratiepro-
dukten in de urine tijdens indomethacine bij patiënten met een 
glomerulonefritis hoeft niet te wijzen op een vermindering van 
intraglomerulaire stolling en dus op een gunstig effect op het 
beloop van een glomerulonefritis, maar kan eenvoudig gezien 
worden als een verminderde uitscheiding van deze moleculen, equi-
valent aan de vermindering van de Proteinurie. 
- dit proefschrift 
3 
De verhoogde klaring van PVP moleculen groter dan 40 A, die is be-
schreven bij vele patiënten met een nefrotisch syndroom, berust 
mogelijk op een angiotensine effect. 
- d i t proefschrift 
4 
Er zijn geen valide gegevens bekend die aantonen dat juxtamedul-
laire nefronen een andere permeabiliteitskarakteristiek vertonen 
voor macromoleculen dan corticale. 
- dit proefschrift 
5 
Bij de mens is minder hypovolaemie nodig om een eiwituitscheiding-
verlagend effect van indomethacine te verkrijgen dan bij de 
PVG/c rat. Dit soort verschillen dient men te overwegen bij het 
transponeren van nierfysiologische gegevens van de rat op de mens. 
- dit proefschrift 
- Gribnau, F.W.J. (1975) Proefschrift, Nijmegen 
б 
Het achterlaten van een drain in het foramen Winslowi na een een­
voudige cholecystectomie is niet zinvol. 
- Kambouris, A.A., Carpenter, W.S., Allaben, R.D. (1973): Cholecystectomy 
without drainage. 
Surg. Gynaecol. Obstet. 137, 613. 
- Ross, F.P., Quinlan, R.M. (1975): Eight hundred cholecystectomies. 
Arch. Surg. 110, 721. 
- Man, В., Kraus, L., Motovic, A. (1977): Cholecystectomy without drainage, 
nasogastric suction and intravenous fluids. 
Am. J. Surg. 133, 312. 
7 
Het verdient overweging het huidige Practisch Onderwijs Genees­
kunde, zoals gegeven in het nieuwe curriculum, te vervangen door 
een juniorcoschap waarbij de individuele student gedurende enkele 
weken wordt toegevoegd aan klinisch werkzame medici. 
8 
De indicatie tot open hartchirurgie mag bij patiënten die worden 
behandeld met chronisch intermitterende haemodialyse, of die ver-
keren in de fase van praeterminale nierinsufficientie, niet af-
hankelijk gesteld worden van de nierfunktie, maar behoort te 
worden bepaald door de cardiale prognose. 
9 
Een t o t a l e a f s l u i t i n g van de a r t e r i a r e n a l i s b e t e k e n t n i e t b i j 
v o o r b a a t d a t de n i e r n i e t meer v i a b e l i s . Een poging t o t r e v a s c u -
l a r i s a t i e na h i s t o l o g i s c h onderzoek van h e t n i e r w e e f s e l i s g e -
ï n d i c e e r d wanneer d i t wee f se l v i t a a l b l i j k t . 
- Hertzer, N.R., Montie, J .E . , Hall, P.M. (1976): Revascularisation of the 
kidney after occlusion of the aorta and both renal a r t e r i es . 
Surgery 79, 52. 
10 
Een plasma cholesterol verlagende therapie mag pas als zinvol 
worden beschouwd wanneer is aangetoond dat onder invloed van de 
therapie het high density lipoorotein cholesterol niet wordt ver-
laagd. 
11 
De emancipatie van de vrouw kan niet los gezien worden van de 
en^ncipatie van de man en is daarmee een opvoedingsprobleem. 
Een opvoeding tot minder starre rollenpatronen voor jongens en 
meisjes, door zowel vaders als moeders, vormt de basis voor een 
oplossing. 
12 
Voorstanders van het Hegeliaanse systeemdenken in de mensweten-
schappen dienen zich te realiseren dat bij de praktische uit-
voering van hun thesen gemakkelijk situaties kunnen ontstaan die 
niet het belang van de mens dienen, door het ontbreken van 
adequate dialectiek en antithese. 


